id	sid	tid	token	lemma	pos
ajlm-429	1	1	abstract	abstract	ADJ
ajlm-429	1	2	introduction	introduction	NOUN
ajlm-429	1	3	methods	method	NOUN
ajlm-429	1	4	results	result	VERB
ajlm-429	1	5	discussion	discussion	NOUN
ajlm-429	1	6	acknowledgements	acknowledgement	NOUN
ajlm-429	1	7	references	reference	NOUN
ajlm-429	1	8	about	about	ADP
ajlm-429	1	9	the	the	DET
ajlm-429	1	10	author(s	author(s	NOUN
ajlm-429	1	11	)	)	PUNCT
ajlm-429	1	12	sam	sam	PROPN
ajlm-429	1	13	l.	l.	PROPN
ajlm-429	1	14	nsobya	nsobya	PROPN
ajlm-429	1	15	department	department	PROPN
ajlm-429	1	16	of	of	ADP
ajlm-429	1	17	pathology	pathology	PROPN
ajlm-429	1	18	,	,	PUNCT
ajlm-429	1	19	school	school	NOUN
ajlm-429	1	20	of	of	ADP
ajlm-429	1	21	biomedical	biomedical	ADJ
ajlm-429	1	22	science	science	NOUN
ajlm-429	1	23	,	,	PUNCT
ajlm-429	1	24	makerere	makerere	NOUN
ajlm-429	1	25	university	university	NOUN
ajlm-429	1	26	,	,	PUNCT
ajlm-429	1	27	kampala	kampala	PROPN
ajlm-429	1	28	,	,	PUNCT
ajlm-429	1	29	uganda	uganda	PROPN
ajlm-429	1	30	paul	paul	PROPN
ajlm-429	1	31	c.	c.	PROPN
ajlm-429	1	32	hewett	hewett	PROPN
ajlm-429	1	33	population	population	PROPN
ajlm-429	1	34	council	council	PROPN
ajlm-429	1	35	,	,	PUNCT
ajlm-429	1	36	washington	washington	PROPN
ajlm-429	1	37	,	,	PUNCT
ajlm-429	1	38	district	district	PROPN
ajlm-429	1	39	of	of	ADP
ajlm-429	1	40	columbia	columbia	PROPN
ajlm-429	1	41	,	,	PUNCT
ajlm-429	1	42	united	united	PROPN
ajlm-429	1	43	states	states	PROPN
ajlm-429	1	44	sam	sam	PROPN
ajlm-429	1	45	kalibala	kalibala	PROPN
ajlm-429	1	46	population	population	PROPN
ajlm-429	1	47	council	council	PROPN
ajlm-429	1	48	,	,	PUNCT
ajlm-429	1	49	washington	washington	PROPN
ajlm-429	1	50	,	,	PUNCT
ajlm-429	1	51	district	district	PROPN
ajlm-429	1	52	of	of	ADP
ajlm-429	1	53	columbia	columbia	PROPN
ajlm-429	1	54	,	,	PUNCT
ajlm-429	1	55	united	united	PROPN
ajlm-429	1	56	states	states	PROPN
ajlm-429	1	57	barbara	barbara	PROPN
ajlm-429	1	58	s.	s.	PROPN
ajlm-429	1	59	mensch	mensch	PROPN
ajlm-429	1	60	population	population	PROPN
ajlm-429	1	61	council	council	PROPN
ajlm-429	1	62	,	,	PUNCT
ajlm-429	1	63	new	new	PROPN
ajlm-429	1	64	york	york	PROPN
ajlm-429	1	65	,	,	PUNCT
ajlm-429	1	66	new	new	PROPN
ajlm-429	1	67	york	york	PROPN
ajlm-429	1	68	,	,	PUNCT
ajlm-429	1	69	united	unite	VERB
ajlm-429	1	70	statesphewett@popcouncil.org	statesphewett@popcouncil.org	PROPN
ajlm-429	1	71	citation	citation	PROPN
ajlm-429	1	72	nsobya	nsobya	PROPN
ajlm-429	1	73	sl	sl	PROPN
ajlm-429	1	74	,	,	PUNCT
ajlm-429	1	75	hewett	hewett	PROPN
ajlm-429	1	76	pc	pc	PROPN
ajlm-429	1	77	,	,	PUNCT
ajlm-429	1	78	kalibala	kalibala	PROPN
ajlm-429	1	79	s	s	PROPN
ajlm-429	1	80	,	,	PUNCT
ajlm-429	1	81	mensch	mensch	PROPN
ajlm-429	1	82	bs	bs	PROPN
ajlm-429	1	83	.	.	PUNCT
ajlm-429	2	1	performance	performance	NOUN
ajlm-429	2	2	of	of	ADP
ajlm-429	2	3	kalon	kalon	PROPN
ajlm-429	2	4	herpes	herpe	NOUN
ajlm-429	2	5	simplex	simplex	NOUN
ajlm-429	2	6	virus	virus	NOUN
ajlm-429	2	7	2	2	NUM
ajlm-429	2	8	assay	assay	NOUN
ajlm-429	2	9	using	use	VERB
ajlm-429	2	10	dried	dry	VERB
ajlm-429	2	11	blood	blood	NOUN
ajlm-429	2	12	spots	spot	NOUN
ajlm-429	2	13	among	among	ADP
ajlm-429	2	14	young	young	ADJ
ajlm-429	2	15	women	woman	NOUN
ajlm-429	2	16	in	in	ADP
ajlm-429	2	17	uganda	uganda	PROPN
ajlm-429	2	18	.	.	PUNCT
ajlm-429	3	1	afr	afr	PROPN
ajlm-429	3	2	j	j	PROPN
ajlm-429	3	3	lab	lab	PROPN
ajlm-429	3	4	med	med	PROPN
ajlm-429	3	5	.	.	PROPN
ajlm-429	3	6	2016;5(1	2016;5(1	NUM
ajlm-429	3	7	)	)	PUNCT
ajlm-429	3	8	,	,	PUNCT
ajlm-429	3	9	a429	a429	PROPN
ajlm-429	3	10	.	.	PROPN
ajlm-429	3	11	http://dx.doi.org/10.4102/ajlm.v5i1.429	http://dx.doi.org/10.4102/ajlm.v5i1.429	PROPN
ajlm-429	3	12	brief	brief	ADJ
ajlm-429	3	13	report	report	NOUN
ajlm-429	3	14	performance	performance	NOUN
ajlm-429	3	15	of	of	ADP
ajlm-429	3	16	kalon	kalon	PROPN
ajlm-429	3	17	herpes	herpe	NOUN
ajlm-429	3	18	simplex	simplex	NOUN
ajlm-429	3	19	virus	virus	NOUN
ajlm-429	3	20	2	2	NUM
ajlm-429	3	21	assay	assay	NOUN
ajlm-429	3	22	using	use	VERB
ajlm-429	3	23	dried	dry	VERB
ajlm-429	3	24	blood	blood	NOUN
ajlm-429	3	25	spots	spot	NOUN
ajlm-429	3	26	among	among	ADP
ajlm-429	3	27	young	young	ADJ
ajlm-429	3	28	women	woman	NOUN
ajlm-429	3	29	in	in	ADP
ajlm-429	3	30	uganda	uganda	PROPN
ajlm-429	3	31	sam	sam	PROPN
ajlm-429	3	32	l.	l.	PROPN
ajlm-429	3	33	nsobya	nsobya	PROPN
ajlm-429	3	34	,	,	PUNCT
ajlm-429	3	35	paul	paul	PROPN
ajlm-429	3	36	c.	c.	PROPN
ajlm-429	3	37	hewett	hewett	PROPN
ajlm-429	3	38	,	,	PUNCT
ajlm-429	3	39	sam	sam	PROPN
ajlm-429	3	40	kalibala	kalibala	PROPN
ajlm-429	3	41	,	,	PUNCT
ajlm-429	3	42	barbara	barbara	PROPN
ajlm-429	3	43	s.	s.	PROPN
ajlm-429	3	44	mensch	mensch	PROPN
ajlm-429	3	45	received	receive	VERB
ajlm-429	3	46	:	:	PUNCT
ajlm-429	3	47	24	24	NUM
ajlm-429	3	48	feb	feb	NOUN
ajlm-429	3	49	.	.	PROPN
ajlm-429	3	50	2016	2016	NUM
ajlm-429	3	51	;	;	PUNCT
ajlm-429	3	52	accepted	accept	VERB
ajlm-429	3	53	:	:	PUNCT
ajlm-429	3	54	25	25	NUM
ajlm-429	3	55	may	may	PROPN
ajlm-429	3	56	2016	2016	NUM
ajlm-429	3	57	;	;	PUNCT
ajlm-429	3	58	published	publish	VERB
ajlm-429	3	59	:	:	PUNCT
ajlm-429	3	60	16	16	NUM
ajlm-429	3	61	aug	aug	PROPN
ajlm-429	3	62	.	.	PROPN
ajlm-429	4	1	2016	2016	NUM
ajlm-429	4	2	copyright	copyright	NOUN
ajlm-429	4	3	:	:	PUNCT
ajlm-429	4	4	©	©	PROPN
ajlm-429	4	5	2016	2016	NUM
ajlm-429	4	6	.	.	PUNCT
ajlm-429	5	1	the	the	DET
ajlm-429	5	2	author(s	author(s	PROPN
ajlm-429	5	3	)	)	PUNCT
ajlm-429	5	4	.	.	PUNCT
ajlm-429	6	1	licensee	licensee	NOUN
ajlm-429	6	2	:	:	PUNCT
ajlm-429	6	3	aosis	aosis	NOUN
ajlm-429	6	4	.	.	PUNCT
ajlm-429	7	1	this	this	PRON
ajlm-429	7	2	is	be	AUX
ajlm-429	7	3	an	an	DET
ajlm-429	7	4	open	open	ADJ
ajlm-429	7	5	access	access	NOUN
ajlm-429	7	6	article	article	NOUN
ajlm-429	7	7	distributed	distribute	VERB
ajlm-429	7	8	under	under	ADP
ajlm-429	7	9	the	the	DET
ajlm-429	7	10	terms	term	NOUN
ajlm-429	7	11	of	of	ADP
ajlm-429	7	12	the	the	DET
ajlm-429	7	13	creative	creative	ADJ
ajlm-429	7	14	commons	common	NOUN
ajlm-429	7	15	attribution	attribution	NOUN
ajlm-429	7	16	license	license	NOUN
ajlm-429	7	17	,	,	PUNCT
ajlm-429	7	18	which	which	PRON
ajlm-429	7	19	permits	permit	VERB
ajlm-429	7	20	unrestricted	unrestricted	ADJ
ajlm-429	7	21	use	use	NOUN
ajlm-429	7	22	,	,	PUNCT
ajlm-429	7	23	distribution	distribution	NOUN
ajlm-429	7	24	,	,	PUNCT
ajlm-429	7	25	and	and	CCONJ
ajlm-429	7	26	reproduction	reproduction	NOUN
ajlm-429	7	27	in	in	ADP
ajlm-429	7	28	any	any	DET
ajlm-429	7	29	medium	medium	NOUN
ajlm-429	7	30	,	,	PUNCT
ajlm-429	7	31	provided	provide	VERB
ajlm-429	7	32	the	the	DET
ajlm-429	7	33	original	original	ADJ
ajlm-429	7	34	work	work	NOUN
ajlm-429	7	35	is	be	AUX
ajlm-429	7	36	properly	properly	ADV
ajlm-429	7	37	cited	cite	VERB
ajlm-429	7	38	.	.	PUNCT
ajlm-429	8	1	abstract	abstract	ADJ
ajlm-429	8	2	this	this	DET
ajlm-429	8	3	study	study	NOUN
ajlm-429	8	4	evaluated	evaluate	VERB
ajlm-429	8	5	the	the	DET
ajlm-429	8	6	performance	performance	NOUN
ajlm-429	8	7	of	of	ADP
ajlm-429	8	8	the	the	DET
ajlm-429	8	9	kalon	kalon	PROPN
ajlm-429	8	10	biological	biological	PROPN
ajlm-429	8	11	hsv2	hsv2	PROPN
ajlm-429	8	12	igg	igg	PROPN
ajlm-429	8	13	enzyme	enzyme	NOUN
ajlm-429	8	14	-	-	PUNCT
ajlm-429	8	15	linked	link	VERB
ajlm-429	8	16	immunosorbent	immunosorbent	NOUN
ajlm-429	8	17	assay	assay	NOUN
ajlm-429	8	18	(	(	PUNCT
ajlm-429	8	19	kalon	kalon	PROPN
ajlm-429	8	20	biological	biological	PROPN
ajlm-429	8	21	ltd	ltd	PROPN
ajlm-429	8	22	,	,	PUNCT
ajlm-429	8	23	surrey	surrey	PROPN
ajlm-429	8	24	,	,	PUNCT
ajlm-429	8	25	united	united	ADJ
ajlm-429	8	26	kingdom	kingdom	PROPN
ajlm-429	8	27	)	)	PUNCT
ajlm-429	8	28	on	on	ADP
ajlm-429	8	29	dried	dry	VERB
ajlm-429	8	30	blood	blood	NOUN
ajlm-429	8	31	spots	spot	NOUN
ajlm-429	8	32	(	(	PUNCT
ajlm-429	8	33	dbs	dbs	PROPN
ajlm-429	8	34	)	)	PUNCT
ajlm-429	8	35	of	of	ADP
ajlm-429	8	36	various	various	ADJ
ajlm-429	8	37	dilutions	dilution	NOUN
ajlm-429	8	38	compared	compare	VERB
ajlm-429	8	39	with	with	ADP
ajlm-429	8	40	plasma	plasma	NOUN
ajlm-429	8	41	from	from	ADP
ajlm-429	8	42	young	young	ADJ
ajlm-429	8	43	women	woman	NOUN
ajlm-429	8	44	aged	age	VERB
ajlm-429	8	45	18–24	18–24	NUM
ajlm-429	8	46	years	year	NOUN
ajlm-429	8	47	in	in	ADP
ajlm-429	8	48	uganda	uganda	PROPN
ajlm-429	8	49	.	.	PUNCT
ajlm-429	9	1	we	we	PRON
ajlm-429	9	2	estimated	estimate	VERB
ajlm-429	9	3	the	the	DET
ajlm-429	9	4	sensitivity	sensitivity	NOUN
ajlm-429	9	5	and	and	CCONJ
ajlm-429	9	6	specificity	specificity	NOUN
ajlm-429	9	7	of	of	ADP
ajlm-429	9	8	three	three	NUM
ajlm-429	9	9	dbs	dbs	NOUN
ajlm-429	9	10	dilutions	dilution	NOUN
ajlm-429	9	11	using	use	VERB
ajlm-429	9	12	plasma	plasma	NOUN
ajlm-429	9	13	as	as	ADP
ajlm-429	9	14	the	the	DET
ajlm-429	9	15	reference	reference	NOUN
ajlm-429	9	16	.	.	PUNCT
ajlm-429	10	1	all	all	DET
ajlm-429	10	2	three	three	NUM
ajlm-429	10	3	evaluated	evaluate	VERB
ajlm-429	10	4	dbs	dbs	NOUN
ajlm-429	10	5	dilutions	dilution	NOUN
ajlm-429	10	6	yielded	yield	VERB
ajlm-429	10	7	low	low	ADJ
ajlm-429	10	8	sensitivities	sensitivity	NOUN
ajlm-429	10	9	and	and	CCONJ
ajlm-429	10	10	specificities	specificity	NOUN
ajlm-429	10	11	,	,	PUNCT
ajlm-429	10	12	with	with	ADP
ajlm-429	10	13	dbs	dbs	PROPN
ajlm-429	10	14	1:2	1:2	NUM
ajlm-429	10	15	yielding	yield	VERB
ajlm-429	10	16	the	the	DET
ajlm-429	10	17	highest	high	ADJ
ajlm-429	10	18	concurrence	concurrence	NOUN
ajlm-429	10	19	.	.	PUNCT
ajlm-429	11	1	other	other	ADJ
ajlm-429	11	2	herpes	herpe	NOUN
ajlm-429	11	3	simplex	simplex	NOUN
ajlm-429	11	4	virus	virus	NOUN
ajlm-429	11	5	type	type	NOUN
ajlm-429	11	6	2	2	NUM
ajlm-429	11	7	assays	assay	NOUN
ajlm-429	11	8	should	should	AUX
ajlm-429	11	9	be	be	AUX
ajlm-429	11	10	examined	examine	VERB
ajlm-429	11	11	with	with	ADP
ajlm-429	11	12	regard	regard	NOUN
ajlm-429	11	13	to	to	ADP
ajlm-429	11	14	their	their	PRON
ajlm-429	11	15	utility	utility	NOUN
ajlm-429	11	16	for	for	ADP
ajlm-429	11	17	testing	test	VERB
ajlm-429	11	18	dbs	dbs	PROPN
ajlm-429	11	19	.	.	PROPN
ajlm-429	12	1	introduction	introduction	NOUN
ajlm-429	12	2	herpes	herpe	NOUN
ajlm-429	12	3	simplex	simplex	NOUN
ajlm-429	12	4	virus	virus	NOUN
ajlm-429	12	5	type	type	NOUN
ajlm-429	12	6	2	2	NUM
ajlm-429	12	7	(	(	PUNCT
ajlm-429	12	8	hsv-2	hsv-2	NUM
ajlm-429	12	9	)	)	PUNCT
ajlm-429	12	10	causes	cause	VERB
ajlm-429	12	11	lifelong	lifelong	ADJ
ajlm-429	12	12	infections	infection	NOUN
ajlm-429	12	13	in	in	ADP
ajlm-429	12	14	exposed	expose	VERB
ajlm-429	12	15	individuals	individual	NOUN
ajlm-429	12	16	and	and	CCONJ
ajlm-429	12	17	is	be	AUX
ajlm-429	12	18	a	a	DET
ajlm-429	12	19	useful	useful	ADJ
ajlm-429	12	20	cumulative	cumulative	ADJ
ajlm-429	12	21	marker	marker	NOUN
ajlm-429	12	22	for	for	ADP
ajlm-429	12	23	unprotected	unprotected	ADJ
ajlm-429	12	24	sex	sex	NOUN
ajlm-429	12	25	.	.	PUNCT
ajlm-429	13	1	hsv-2	hsv-2	PUNCT
ajlm-429	13	2	infection	infection	NOUN
ajlm-429	13	3	has	have	AUX
ajlm-429	13	4	also	also	ADV
ajlm-429	13	5	been	be	AUX
ajlm-429	13	6	shown	show	VERB
ajlm-429	13	7	to	to	PART
ajlm-429	13	8	be	be	AUX
ajlm-429	13	9	an	an	DET
ajlm-429	13	10	important	important	ADJ
ajlm-429	13	11	co	co	NOUN
ajlm-429	13	12	-	-	NOUN
ajlm-429	13	13	infection	infection	NOUN
ajlm-429	13	14	for	for	ADP
ajlm-429	13	15	hiv	hiv	PROPN
ajlm-429	13	16	,	,	PUNCT
ajlm-429	13	17	facilitating	facilitate	VERB
ajlm-429	13	18	hiv	hiv	PROPN
ajlm-429	13	19	acquisition	acquisition	NOUN
ajlm-429	13	20	and	and	CCONJ
ajlm-429	13	21	transmission	transmission	NOUN
ajlm-429	13	22	,	,	PUNCT
ajlm-429	13	23	and	and	CCONJ
ajlm-429	13	24	accelerating	accelerate	VERB
ajlm-429	13	25	disease	disease	NOUN
ajlm-429	13	26	progression.1	progression.1	PROPN
ajlm-429	13	27	in	in	ADP
ajlm-429	13	28	uganda	uganda	PROPN
ajlm-429	13	29	,	,	PUNCT
ajlm-429	13	30	it	it	PRON
ajlm-429	13	31	is	be	AUX
ajlm-429	13	32	estimated	estimate	VERB
ajlm-429	13	33	that	that	SCONJ
ajlm-429	13	34	about	about	ADV
ajlm-429	13	35	half	half	NOUN
ajlm-429	13	36	of	of	ADP
ajlm-429	13	37	adults	adult	NOUN
ajlm-429	13	38	aged	age	VERB
ajlm-429	13	39	15–59	15–59	NUM
ajlm-429	13	40	years	year	NOUN
ajlm-429	13	41	are	be	AUX
ajlm-429	13	42	infected	infect	VERB
ajlm-429	13	43	with	with	ADP
ajlm-429	13	44	hsv-2.2	hsv-2.2	NUM
ajlm-429	13	45	numerous	numerous	ADJ
ajlm-429	13	46	studies	study	NOUN
ajlm-429	13	47	have	have	AUX
ajlm-429	13	48	outlined	outline	VERB
ajlm-429	13	49	the	the	DET
ajlm-429	13	50	usefulness	usefulness	NOUN
ajlm-429	13	51	of	of	ADP
ajlm-429	13	52	dried	dry	VERB
ajlm-429	13	53	blood	blood	NOUN
ajlm-429	13	54	spots	spot	NOUN
ajlm-429	13	55	(	(	PUNCT
ajlm-429	13	56	dbs	dbs	PROPN
ajlm-429	13	57	)	)	PUNCT
ajlm-429	13	58	for	for	ADP
ajlm-429	13	59	the	the	DET
ajlm-429	13	60	serologic	serologic	ADJ
ajlm-429	13	61	diagnosis	diagnosis	NOUN
ajlm-429	13	62	of	of	ADP
ajlm-429	13	63	infectious	infectious	ADJ
ajlm-429	13	64	diseases	disease	NOUN
ajlm-429	13	65	,	,	PUNCT
ajlm-429	13	66	as	as	ADV
ajlm-429	13	67	well	well	ADV
ajlm-429	13	68	as	as	ADP
ajlm-429	13	69	for	for	ADP
ajlm-429	13	70	large	large	ADJ
ajlm-429	13	71	-	-	PUNCT
ajlm-429	13	72	scale	scale	NOUN
ajlm-429	13	73	seroprevalence	seroprevalence	NOUN
ajlm-429	13	74	studies.3,4,5,6,7	studies.3,4,5,6,7	NOUN
ajlm-429	14	1	since	since	SCONJ
ajlm-429	14	2	dbs	dbs	PROPN
ajlm-429	14	3	do	do	AUX
ajlm-429	14	4	not	not	PART
ajlm-429	14	5	require	require	VERB
ajlm-429	14	6	immediate	immediate	ADJ
ajlm-429	14	7	refrigeration	refrigeration	NOUN
ajlm-429	14	8	,	,	PUNCT
ajlm-429	14	9	occupy	occupy	VERB
ajlm-429	14	10	little	little	ADJ
ajlm-429	14	11	space	space	NOUN
ajlm-429	14	12	and	and	CCONJ
ajlm-429	14	13	are	be	AUX
ajlm-429	14	14	easily	easily	ADV
ajlm-429	14	15	transported	transport	VERB
ajlm-429	14	16	,	,	PUNCT
ajlm-429	14	17	they	they	PRON
ajlm-429	14	18	are	be	AUX
ajlm-429	14	19	an	an	DET
ajlm-429	14	20	attractive	attractive	ADJ
ajlm-429	14	21	means	mean	NOUN
ajlm-429	14	22	for	for	ADP
ajlm-429	14	23	biomarker	biomarker	NOUN
ajlm-429	14	24	-	-	PUNCT
ajlm-429	14	25	based	base	VERB
ajlm-429	14	26	studies	study	NOUN
ajlm-429	14	27	,	,	PUNCT
ajlm-429	14	28	particularly	particularly	ADV
ajlm-429	14	29	in	in	ADP
ajlm-429	14	30	geographic	geographic	ADJ
ajlm-429	14	31	settings	setting	NOUN
ajlm-429	14	32	with	with	ADP
ajlm-429	14	33	limited	limited	ADJ
ajlm-429	14	34	laboratory	laboratory	NOUN
ajlm-429	14	35	resources	resource	NOUN
ajlm-429	14	36	.	.	PUNCT
ajlm-429	15	1	recently	recently	ADV
ajlm-429	15	2	-	-	PUNCT
ajlm-429	15	3	developed	develop	VERB
ajlm-429	15	4	type	type	NOUN
ajlm-429	15	5	-	-	PUNCT
ajlm-429	15	6	specific	specific	ADJ
ajlm-429	15	7	hsv	hsv	NOUN
ajlm-429	15	8	antibody	antibody	NOUN
ajlm-429	15	9	tests	test	NOUN
ajlm-429	15	10	are	be	AUX
ajlm-429	15	11	based	base	VERB
ajlm-429	15	12	on	on	ADP
ajlm-429	15	13	the	the	DET
ajlm-429	15	14	detection	detection	NOUN
ajlm-429	15	15	of	of	ADP
ajlm-429	15	16	antibodies	antibody	NOUN
ajlm-429	15	17	to	to	ADP
ajlm-429	15	18	glycoprotein	glycoprotein	NOUN
ajlm-429	15	19	g1	g1	PROPN
ajlm-429	15	20	(	(	PUNCT
ajlm-429	15	21	gg1	gg1	NOUN
ajlm-429	15	22	)	)	PUNCT
ajlm-429	15	23	,	,	PUNCT
ajlm-429	15	24	a	a	DET
ajlm-429	15	25	marker	marker	NOUN
ajlm-429	15	26	for	for	ADP
ajlm-429	15	27	hsv-1	hsv-1	DET
ajlm-429	15	28	infection	infection	NOUN
ajlm-429	15	29	,	,	PUNCT
ajlm-429	15	30	and	and	CCONJ
ajlm-429	15	31	glycoprotein	glycoprotein	PROPN
ajlm-429	15	32	g2	g2	PROPN
ajlm-429	15	33	(	(	PUNCT
ajlm-429	15	34	gg2	gg2	PROPN
ajlm-429	15	35	)	)	PUNCT
ajlm-429	15	36	,	,	PUNCT
ajlm-429	15	37	a	a	DET
ajlm-429	15	38	marker	marker	NOUN
ajlm-429	15	39	for	for	ADP
ajlm-429	15	40	hsv-2	hsv-2	PUNCT
ajlm-429	15	41	infection.8,9	infection.8,9	PRON
ajlm-429	15	42	validation	validation	NOUN
ajlm-429	15	43	of	of	ADP
ajlm-429	15	44	dbs	dbs	NOUN
ajlm-429	15	45	for	for	ADP
ajlm-429	15	46	immunoglobulin	immunoglobulin	NOUN
ajlm-429	15	47	g	g	PROPN
ajlm-429	15	48	(	(	PUNCT
ajlm-429	15	49	igg)-based	igg)-base	VERB
ajlm-429	15	50	tests	test	NOUN
ajlm-429	15	51	has	have	AUX
ajlm-429	15	52	been	be	AUX
ajlm-429	15	53	conducted	conduct	VERB
ajlm-429	15	54	using	use	VERB
ajlm-429	15	55	hsv-1	hsv-1	ADJ
ajlm-429	15	56	-	-	PUNCT
ajlm-429	15	57	positive	positive	ADJ
ajlm-429	15	58	antibody	antibody	NOUN
ajlm-429	15	59	samples	sample	NOUN
ajlm-429	15	60	from	from	ADP
ajlm-429	15	61	22	22	NUM
ajlm-429	15	62	healthy	healthy	ADJ
ajlm-429	15	63	volunteers.10	volunteers.10	NOUN
ajlm-429	15	64	hogrefe	hogrefe	NOUN
ajlm-429	15	65	,	,	PUNCT
ajlm-429	15	66	ernst	ernst	PROPN
ajlm-429	15	67	and	and	CCONJ
ajlm-429	15	68	su	su	PROPN
ajlm-429	15	69	reported	report	VERB
ajlm-429	15	70	that	that	SCONJ
ajlm-429	15	71	testing	testing	NOUN
ajlm-429	15	72	data	datum	NOUN
ajlm-429	15	73	using	use	VERB
ajlm-429	15	74	a	a	DET
ajlm-429	15	75	single	single	ADJ
ajlm-429	15	76	dilution	dilution	NOUN
ajlm-429	15	77	of	of	ADP
ajlm-429	15	78	dbs	dbs	PROPN
ajlm-429	15	79	eluates	eluate	NOUN
ajlm-429	15	80	(	(	PUNCT
ajlm-429	15	81	1:4	1:4	NUM
ajlm-429	15	82	)	)	PUNCT
ajlm-429	15	83	with	with	ADP
ajlm-429	15	84	the	the	DET
ajlm-429	15	85	hsv	hsv	PROPN
ajlm-429	15	86	type	type	NOUN
ajlm-429	15	87	-	-	PUNCT
ajlm-429	15	88	specific	specific	ADJ
ajlm-429	15	89	enzyme	enzyme	NOUN
ajlm-429	15	90	-	-	PUNCT
ajlm-429	15	91	linked	link	VERB
ajlm-429	15	92	immunosorbent	immunosorbent	NOUN
ajlm-429	15	93	assay	assay	PROPN
ajlm-429	15	94	(	(	PUNCT
ajlm-429	15	95	elisa	elisa	NOUN
ajlm-429	15	96	)	)	PUNCT
ajlm-429	15	97	method	method	NOUN
ajlm-429	15	98	were	be	AUX
ajlm-429	15	99	similar	similar	ADJ
ajlm-429	15	100	to	to	ADP
ajlm-429	15	101	those	those	PRON
ajlm-429	15	102	of	of	ADP
ajlm-429	15	103	sera	sera	NOUN
ajlm-429	15	104	diluted	dilute	VERB
ajlm-429	15	105	to	to	ADP
ajlm-429	15	106	1:101	1:101	NUM
ajlm-429	15	107	using	use	VERB
ajlm-429	15	108	the	the	DET
ajlm-429	15	109	standard	standard	ADJ
ajlm-429	15	110	herpeselect	herpeselect	NOUN
ajlm-429	15	111	®	®	NOUN
ajlm-429	15	112	elisa	elisa	NOUN
ajlm-429	15	113	(	(	PUNCT
ajlm-429	15	114	focus	focus	NOUN
ajlm-429	15	115	diagnostics	diagnostic	NOUN
ajlm-429	15	116	,	,	PUNCT
ajlm-429	15	117	california	california	PROPN
ajlm-429	15	118	,	,	PUNCT
ajlm-429	15	119	united	unite	VERB
ajlm-429	15	120	states).10	states).10	PROPN
ajlm-429	15	121	the	the	DET
ajlm-429	15	122	efficiency	efficiency	NOUN
ajlm-429	15	123	of	of	ADP
ajlm-429	15	124	using	use	VERB
ajlm-429	15	125	igg	igg	PROPN
ajlm-429	15	126	eluted	elute	VERB
ajlm-429	15	127	from	from	ADP
ajlm-429	15	128	dbs	dbs	PROPN
ajlm-429	15	129	samples	sample	NOUN
ajlm-429	15	130	was	be	AUX
ajlm-429	15	131	found	find	VERB
ajlm-429	15	132	to	to	PART
ajlm-429	15	133	be	be	AUX
ajlm-429	15	134	consistent	consistent	ADJ
ajlm-429	15	135	with	with	ADP
ajlm-429	15	136	measurements	measurement	NOUN
ajlm-429	15	137	of	of	ADP
ajlm-429	15	138	igg	igg	NOUN
ajlm-429	15	139	concentrations	concentration	NOUN
ajlm-429	15	140	in	in	ADP
ajlm-429	15	141	most	most	ADJ
ajlm-429	15	142	corresponding	corresponding	ADJ
ajlm-429	15	143	serum	serum	NOUN
ajlm-429	15	144	samples	sample	NOUN
ajlm-429	15	145	.	.	PUNCT
ajlm-429	16	1	however	however	ADV
ajlm-429	16	2	,	,	PUNCT
ajlm-429	16	3	results	result	NOUN
ajlm-429	16	4	have	have	AUX
ajlm-429	16	5	been	be	AUX
ajlm-429	16	6	inconsistent	inconsistent	ADJ
ajlm-429	16	7	when	when	SCONJ
ajlm-429	16	8	using	use	VERB
ajlm-429	16	9	the	the	DET
ajlm-429	16	10	kalon	kalon	NOUN
ajlm-429	16	11	biological	biological	PROPN
ajlm-429	16	12	hsv2	hsv2	PROPN
ajlm-429	16	13	igg	igg	PROPN
ajlm-429	16	14	elisa	elisa	PROPN
ajlm-429	16	15	assay	assay	PROPN
ajlm-429	16	16	(	(	PUNCT
ajlm-429	16	17	kalon	kalon	PROPN
ajlm-429	16	18	biological	biological	PROPN
ajlm-429	16	19	ltd	ltd	PROPN
ajlm-429	16	20	,	,	PUNCT
ajlm-429	16	21	surrey	surrey	PROPN
ajlm-429	16	22	,	,	PUNCT
ajlm-429	16	23	united	united	ADJ
ajlm-429	16	24	kingdom	kingdom	NOUN
ajlm-429	16	25	;	;	PUNCT
ajlm-429	16	26	hereafter	hereafter	PROPN
ajlm-429	16	27	kalon	kalon	PROPN
ajlm-429	16	28	elisa	elisa	PROPN
ajlm-429	16	29	hsv2	hsv2	PROPN
ajlm-429	16	30	assay	assay	PROPN
ajlm-429	16	31	)	)	PUNCT
ajlm-429	16	32	when	when	SCONJ
ajlm-429	16	33	measuring	measure	VERB
ajlm-429	16	34	antibodies	antibody	NOUN
ajlm-429	16	35	to	to	PART
ajlm-429	16	36	gg2	gg2	VERB
ajlm-429	16	37	with	with	ADP
ajlm-429	16	38	the	the	DET
ajlm-429	16	39	same	same	ADJ
ajlm-429	16	40	testing	testing	NOUN
ajlm-429	16	41	protocol.10	protocol.10	ADJ
ajlm-429	16	42	in	in	ADP
ajlm-429	16	43	a	a	DET
ajlm-429	16	44	household	household	NOUN
ajlm-429	16	45	survey	survey	NOUN
ajlm-429	16	46	conducted	conduct	VERB
ajlm-429	16	47	in	in	ADP
ajlm-429	16	48	2010	2010	NUM
ajlm-429	16	49	,	,	PUNCT
ajlm-429	16	50	sexual	sexual	ADJ
ajlm-429	16	51	behavior	behavior	NOUN
ajlm-429	16	52	data	datum	NOUN
ajlm-429	16	53	and	and	CCONJ
ajlm-429	16	54	dbs	dbs	PROPN
ajlm-429	16	55	specimens	specimen	NOUN
ajlm-429	16	56	were	be	AUX
ajlm-429	16	57	collected	collect	VERB
ajlm-429	16	58	from	from	ADP
ajlm-429	16	59	young	young	ADJ
ajlm-429	16	60	women	woman	NOUN
ajlm-429	16	61	aged	age	VERB
ajlm-429	16	62	18–24	18–24	NUM
ajlm-429	16	63	years	year	NOUN
ajlm-429	16	64	in	in	ADP
ajlm-429	16	65	kampala.11	kampala.11	PROPN
ajlm-429	16	66	when	when	SCONJ
ajlm-429	16	67	a	a	DET
ajlm-429	16	68	1:4	1:4	NUM
ajlm-429	16	69	dilution	dilution	NOUN
ajlm-429	16	70	was	be	AUX
ajlm-429	16	71	applied	apply	VERB
ajlm-429	16	72	to	to	ADP
ajlm-429	16	73	our	our	PRON
ajlm-429	16	74	first	first	ADJ
ajlm-429	16	75	277	277	NUM
ajlm-429	16	76	dbs	dbs	NOUN
ajlm-429	16	77	specimens	specimen	NOUN
ajlm-429	16	78	,	,	PUNCT
ajlm-429	16	79	the	the	DET
ajlm-429	16	80	estimated	estimate	VERB
ajlm-429	16	81	hsv-2	hsv-2	PUNCT
ajlm-429	16	82	prevalence	prevalence	NOUN
ajlm-429	16	83	was	be	AUX
ajlm-429	16	84	2	2	NUM
ajlm-429	16	85	%	%	NOUN
ajlm-429	16	86	.	.	PUNCT
ajlm-429	17	1	this	this	DET
ajlm-429	17	2	prevalence	prevalence	NOUN
ajlm-429	17	3	was	be	AUX
ajlm-429	17	4	significantly	significantly	ADV
ajlm-429	17	5	lower	low	ADJ
ajlm-429	17	6	than	than	SCONJ
ajlm-429	17	7	that	that	PRON
ajlm-429	17	8	reported	report	VERB
ajlm-429	17	9	previously	previously	ADV
ajlm-429	17	10	in	in	ADP
ajlm-429	17	11	the	the	DET
ajlm-429	17	12	2004–2005	2004–2005	NUM
ajlm-429	17	13	uganda	uganda	PROPN
ajlm-429	17	14	hiv	hiv	PROPN
ajlm-429	17	15	/	/	SYM
ajlm-429	17	16	aids	aids	PROPN
ajlm-429	17	17	sero	sero	ADJ
ajlm-429	17	18	-	-	PUNCT
ajlm-429	17	19	behavioural	behavioural	ADJ
ajlm-429	17	20	survey	survey	NOUN
ajlm-429	17	21	(	(	PUNCT
ajlm-429	17	22	uhsbs	uhsbs	NOUN
ajlm-429	17	23	)	)	PUNCT
ajlm-429	17	24	,	,	PUNCT
ajlm-429	17	25	which	which	PRON
ajlm-429	17	26	found	find	VERB
ajlm-429	17	27	a	a	DET
ajlm-429	17	28	prevalence	prevalence	NOUN
ajlm-429	17	29	of	of	ADP
ajlm-429	17	30	21	21	NUM
ajlm-429	17	31	%	%	NOUN
ajlm-429	17	32	among	among	ADP
ajlm-429	17	33	women	woman	NOUN
ajlm-429	17	34	aged	age	VERB
ajlm-429	17	35	15–19	15–19	NUM
ajlm-429	17	36	years	year	NOUN
ajlm-429	17	37	and	and	CCONJ
ajlm-429	17	38	38	38	NUM
ajlm-429	17	39	%	%	NOUN
ajlm-429	17	40	among	among	ADP
ajlm-429	17	41	women	woman	NOUN
ajlm-429	17	42	aged	age	VERB
ajlm-429	17	43	20–24	20–24	NUM
ajlm-429	17	44	years.2	years.2	VERB
ajlm-429	17	45	when	when	SCONJ
ajlm-429	17	46	an	an	DET
ajlm-429	17	47	additional	additional	ADJ
ajlm-429	17	48	10	10	NUM
ajlm-429	17	49	dbs	dbs	NOUN
ajlm-429	17	50	specimens	specimen	NOUN
ajlm-429	17	51	from	from	ADP
ajlm-429	17	52	our	our	PRON
ajlm-429	17	53	sample	sample	NOUN
ajlm-429	17	54	of	of	ADP
ajlm-429	17	55	young	young	ADJ
ajlm-429	17	56	women	woman	NOUN
ajlm-429	17	57	were	be	AUX
ajlm-429	17	58	further	far	ADV
ajlm-429	17	59	analysed	analyse	VERB
ajlm-429	17	60	using	use	VERB
ajlm-429	17	61	a	a	DET
ajlm-429	17	62	dilution	dilution	NOUN
ajlm-429	17	63	of	of	ADP
ajlm-429	17	64	1:2	1:2	NUM
ajlm-429	17	65	,	,	PUNCT
ajlm-429	17	66	the	the	DET
ajlm-429	17	67	prevalence	prevalence	NOUN
ajlm-429	17	68	of	of	ADP
ajlm-429	17	69	hsv-2	hsv-2	NUM
ajlm-429	17	70	increased	increase	VERB
ajlm-429	17	71	three	three	NUM
ajlm-429	17	72	-	-	PUNCT
ajlm-429	17	73	fold.11	fold.11	VERB
ajlm-429	17	74	in	in	ADP
ajlm-429	17	75	the	the	DET
ajlm-429	17	76	study	study	NOUN
ajlm-429	17	77	reported	report	VERB
ajlm-429	17	78	here	here	ADV
ajlm-429	17	79	,	,	PUNCT
ajlm-429	17	80	we	we	PRON
ajlm-429	17	81	examined	examine	VERB
ajlm-429	17	82	the	the	DET
ajlm-429	17	83	performance	performance	NOUN
ajlm-429	17	84	of	of	ADP
ajlm-429	17	85	the	the	DET
ajlm-429	17	86	kalon	kalon	PROPN
ajlm-429	17	87	elisa	elisa	PROPN
ajlm-429	17	88	hsv2	hsv2	PROPN
ajlm-429	17	89	assay	assay	PROPN
ajlm-429	17	90	using	use	VERB
ajlm-429	17	91	dbs	dbs	NOUN
ajlm-429	17	92	and	and	CCONJ
ajlm-429	17	93	plasma	plasma	NOUN
ajlm-429	17	94	samples	sample	NOUN
ajlm-429	17	95	from	from	ADP
ajlm-429	17	96	stored	store	VERB
ajlm-429	17	97	specimens	specimen	NOUN
ajlm-429	17	98	previously	previously	ADV
ajlm-429	17	99	collected	collect	VERB
ajlm-429	17	100	during	during	ADP
ajlm-429	17	101	the	the	DET
ajlm-429	17	102	2004–2005	2004–2005	NUM
ajlm-429	17	103	uhsbs	uhsbs	NOUN
ajlm-429	17	104	.	.	PUNCT
ajlm-429	18	1	the	the	DET
ajlm-429	18	2	dbs	dbs	PROPN
ajlm-429	18	3	laboratory	laboratory	NOUN
ajlm-429	18	4	assessment	assessment	NOUN
ajlm-429	18	5	was	be	AUX
ajlm-429	18	6	conducted	conduct	VERB
ajlm-429	18	7	in	in	ADP
ajlm-429	18	8	late	late	ADJ
ajlm-429	18	9	2010	2010	NUM
ajlm-429	18	10	and	and	CCONJ
ajlm-429	18	11	early	early	ADJ
ajlm-429	18	12	2011	2011	NUM
ajlm-429	18	13	.	.	PUNCT
ajlm-429	19	1	the	the	DET
ajlm-429	19	2	study	study	NOUN
ajlm-429	19	3	goal	goal	NOUN
ajlm-429	19	4	was	be	AUX
ajlm-429	19	5	to	to	PART
ajlm-429	19	6	examine	examine	VERB
ajlm-429	19	7	whether	whether	SCONJ
ajlm-429	19	8	hsv-2	hsv-2	VERB
ajlm-429	19	9	testing	testing	NOUN
ajlm-429	19	10	results	result	NOUN
ajlm-429	19	11	based	base	VERB
ajlm-429	19	12	on	on	ADP
ajlm-429	19	13	dbs	dbs	PROPN
ajlm-429	19	14	at	at	ADP
ajlm-429	19	15	various	various	ADJ
ajlm-429	19	16	dilution	dilution	NOUN
ajlm-429	19	17	levels	level	NOUN
ajlm-429	19	18	were	be	AUX
ajlm-429	19	19	concordant	concordant	ADJ
ajlm-429	19	20	with	with	ADP
ajlm-429	19	21	plasma	plasma	NOUN
ajlm-429	19	22	-	-	PUNCT
ajlm-429	19	23	based	base	VERB
ajlm-429	19	24	results	result	NOUN
ajlm-429	19	25	obtained	obtain	VERB
ajlm-429	19	26	from	from	ADP
ajlm-429	19	27	the	the	DET
ajlm-429	19	28	same	same	ADJ
ajlm-429	19	29	participants	participant	NOUN
ajlm-429	19	30	.	.	PUNCT
ajlm-429	20	1	methods	method	NOUN
ajlm-429	20	2	ethical	ethical	ADJ
ajlm-429	20	3	considerations	consideration	NOUN
ajlm-429	20	4	participants	participant	NOUN
ajlm-429	20	5	who	who	PRON
ajlm-429	20	6	provided	provide	VERB
ajlm-429	20	7	specimens	specimen	NOUN
ajlm-429	20	8	to	to	ADP
ajlm-429	20	9	the	the	DET
ajlm-429	20	10	2004–2005	2004–2005	NUM
ajlm-429	20	11	uhsbs	uhsbs	NOUN
ajlm-429	20	12	consented	consent	VERB
ajlm-429	20	13	to	to	ADP
ajlm-429	20	14	the	the	DET
ajlm-429	20	15	long	long	ADJ
ajlm-429	20	16	-	-	PUNCT
ajlm-429	20	17	term	term	NOUN
ajlm-429	20	18	storage	storage	NOUN
ajlm-429	20	19	and	and	CCONJ
ajlm-429	20	20	future	future	ADJ
ajlm-429	20	21	testing	testing	NOUN
ajlm-429	20	22	of	of	ADP
ajlm-429	20	23	their	their	PRON
ajlm-429	20	24	delinked	delinke	VERB
ajlm-429	20	25	blood	blood	NOUN
ajlm-429	20	26	specimens	specimen	NOUN
ajlm-429	20	27	for	for	ADP
ajlm-429	20	28	which	which	PRON
ajlm-429	20	29	they	they	PRON
ajlm-429	20	30	would	would	AUX
ajlm-429	20	31	not	not	PART
ajlm-429	20	32	receive	receive	VERB
ajlm-429	20	33	results	result	NOUN
ajlm-429	20	34	.	.	PUNCT
ajlm-429	21	1	we	we	PRON
ajlm-429	21	2	obtained	obtain	VERB
ajlm-429	21	3	additional	additional	ADJ
ajlm-429	21	4	permission	permission	NOUN
ajlm-429	21	5	for	for	ADP
ajlm-429	21	6	this	this	DET
ajlm-429	21	7	study	study	NOUN
ajlm-429	21	8	from	from	ADP
ajlm-429	21	9	the	the	DET
ajlm-429	21	10	uganda	uganda	PROPN
ajlm-429	21	11	ministry	ministry	PROPN
ajlm-429	21	12	of	of	ADP
ajlm-429	21	13	health	health	PROPN
ajlm-429	21	14	.	.	PUNCT
ajlm-429	22	1	the	the	DET
ajlm-429	22	2	study	study	NOUN
ajlm-429	22	3	was	be	AUX
ajlm-429	22	4	also	also	ADV
ajlm-429	22	5	reviewed	review	VERB
ajlm-429	22	6	and	and	CCONJ
ajlm-429	22	7	approved	approve	VERB
ajlm-429	22	8	by	by	ADP
ajlm-429	22	9	the	the	DET
ajlm-429	22	10	uganda	uganda	PROPN
ajlm-429	22	11	virus	virus	PROPN
ajlm-429	22	12	research	research	PROPN
ajlm-429	22	13	institute	institute	PROPN
ajlm-429	22	14	’s	’s	PART
ajlm-429	22	15	institutional	institutional	PROPN
ajlm-429	22	16	review	review	PROPN
ajlm-429	22	17	board	board	NOUN
ajlm-429	22	18	(	(	PUNCT
ajlm-429	22	19	gc/127/11/10/15	gc/127/11/10/15	NOUN
ajlm-429	22	20	)	)	PUNCT
ajlm-429	22	21	and	and	CCONJ
ajlm-429	22	22	the	the	DET
ajlm-429	22	23	population	population	NOUN
ajlm-429	22	24	council	council	PROPN
ajlm-429	22	25	institutional	institutional	PROPN
ajlm-429	22	26	review	review	PROPN
ajlm-429	22	27	board	board	NOUN
ajlm-429	22	28	(	(	PUNCT
ajlm-429	22	29	protocol	protocol	NOUN
ajlm-429	22	30	433	433	NUM
ajlm-429	22	31	)	)	PUNCT
ajlm-429	22	32	.	.	PUNCT
ajlm-429	23	1	study	study	NOUN
ajlm-429	23	2	population	population	NOUN
ajlm-429	23	3	this	this	DET
ajlm-429	23	4	study	study	NOUN
ajlm-429	23	5	was	be	AUX
ajlm-429	23	6	conducted	conduct	VERB
ajlm-429	23	7	using	use	VERB
ajlm-429	23	8	existing	exist	VERB
ajlm-429	23	9	stored	store	VERB
ajlm-429	23	10	dbs	dbs	NOUN
ajlm-429	23	11	and	and	CCONJ
ajlm-429	23	12	plasma	plasma	NOUN
ajlm-429	23	13	specimens	specimen	NOUN
ajlm-429	23	14	from	from	ADP
ajlm-429	23	15	the	the	DET
ajlm-429	23	16	2004–2005	2004–2005	NUM
ajlm-429	23	17	uhsbs	uhsbs	NOUN
ajlm-429	23	18	.	.	PUNCT
ajlm-429	24	1	the	the	DET
ajlm-429	24	2	uhsbs	uhsbs	NOUN
ajlm-429	24	3	was	be	AUX
ajlm-429	24	4	a	a	DET
ajlm-429	24	5	nationally	nationally	ADV
ajlm-429	24	6	-	-	PUNCT
ajlm-429	24	7	representative	representative	NOUN
ajlm-429	24	8	household	household	NOUN
ajlm-429	24	9	-	-	PUNCT
ajlm-429	24	10	based	base	VERB
ajlm-429	24	11	survey	survey	NOUN
ajlm-429	24	12	that	that	PRON
ajlm-429	24	13	sampled	sample	VERB
ajlm-429	24	14	19	19	NUM
ajlm-429	24	15	656	656	NUM
ajlm-429	24	16	adult	adult	NOUN
ajlm-429	24	17	respondents	respondent	NOUN
ajlm-429	24	18	.	.	PUNCT
ajlm-429	25	1	the	the	DET
ajlm-429	25	2	main	main	ADJ
ajlm-429	25	3	objective	objective	NOUN
ajlm-429	25	4	of	of	ADP
ajlm-429	25	5	the	the	DET
ajlm-429	25	6	uhsbs	uhsbs	NOUN
ajlm-429	25	7	was	be	AUX
ajlm-429	25	8	to	to	PART
ajlm-429	25	9	obtain	obtain	VERB
ajlm-429	25	10	national	national	ADJ
ajlm-429	25	11	and	and	CCONJ
ajlm-429	25	12	sub	sub	ADJ
ajlm-429	25	13	-	-	ADJ
ajlm-429	25	14	national	national	ADJ
ajlm-429	25	15	estimates	estimate	NOUN
ajlm-429	25	16	of	of	ADP
ajlm-429	25	17	hiv	hiv	PROPN
ajlm-429	25	18	prevalence	prevalence	NOUN
ajlm-429	25	19	and	and	CCONJ
ajlm-429	25	20	selected	select	VERB
ajlm-429	25	21	indicators	indicator	NOUN
ajlm-429	25	22	of	of	ADP
ajlm-429	25	23	hiv	hiv	PROPN
ajlm-429	25	24	-	-	PUNCT
ajlm-429	25	25	related	relate	VERB
ajlm-429	25	26	risk	risk	NOUN
ajlm-429	25	27	behaviours	behaviour	NOUN
ajlm-429	25	28	,	,	PUNCT
ajlm-429	25	29	programme	programme	NOUN
ajlm-429	25	30	coverage	coverage	NOUN
ajlm-429	25	31	and	and	CCONJ
ajlm-429	25	32	hiv	hiv	PROPN
ajlm-429	25	33	knowledge	knowledge	NOUN
ajlm-429	25	34	and	and	CCONJ
ajlm-429	25	35	attitudes	attitude	NOUN
ajlm-429	25	36	.	.	PUNCT
ajlm-429	26	1	one	one	NUM
ajlm-429	26	2	of	of	ADP
ajlm-429	26	3	its	its	PRON
ajlm-429	26	4	specific	specific	ADJ
ajlm-429	26	5	objectives	objective	NOUN
ajlm-429	26	6	was	be	AUX
ajlm-429	26	7	to	to	PART
ajlm-429	26	8	determine	determine	VERB
ajlm-429	26	9	the	the	DET
ajlm-429	26	10	magnitude	magnitude	NOUN
ajlm-429	26	11	and	and	CCONJ
ajlm-429	26	12	distribution	distribution	NOUN
ajlm-429	26	13	of	of	ADP
ajlm-429	26	14	hiv	hiv	PROPN
ajlm-429	26	15	and	and	CCONJ
ajlm-429	26	16	other	other	ADJ
ajlm-429	26	17	sexually	sexually	ADV
ajlm-429	26	18	-	-	PUNCT
ajlm-429	26	19	transmitted	transmit	VERB
ajlm-429	26	20	infections	infection	NOUN
ajlm-429	26	21	,	,	PUNCT
ajlm-429	26	22	such	such	ADJ
ajlm-429	26	23	as	as	ADP
ajlm-429	26	24	hsv-2	hsv-2	NOUN
ajlm-429	26	25	,	,	PUNCT
ajlm-429	26	26	in	in	ADP
ajlm-429	26	27	uganda.2	uganda.2	NOUN
ajlm-429	26	28	the	the	DET
ajlm-429	26	29	uhsbs	uhsbs	NOUN
ajlm-429	26	30	estimated	estimate	VERB
ajlm-429	26	31	the	the	DET
ajlm-429	26	32	national	national	PROPN
ajlm-429	26	33	adult	adult	PROPN
ajlm-429	26	34	prevalence	prevalence	NOUN
ajlm-429	26	35	of	of	ADP
ajlm-429	26	36	hiv	hiv	PROPN
ajlm-429	26	37	at	at	ADP
ajlm-429	26	38	6.4	6.4	NUM
ajlm-429	26	39	%	%	NOUN
ajlm-429	26	40	and	and	CCONJ
ajlm-429	26	41	that	that	PRON
ajlm-429	26	42	of	of	ADP
ajlm-429	26	43	hsv-2	hsv-2	X
ajlm-429	26	44	at	at	ADP
ajlm-429	26	45	44%.2	44%.2	NOUN
ajlm-429	26	46	survey	survey	NOUN
ajlm-429	26	47	specimens	specimen	NOUN
ajlm-429	26	48	and	and	CCONJ
ajlm-429	26	49	testing	testing	NOUN
ajlm-429	26	50	survey	survey	NOUN
ajlm-429	26	51	participants	participant	NOUN
ajlm-429	26	52	had	have	VERB
ajlm-429	26	53	venous	venous	ADJ
ajlm-429	26	54	blood	blood	NOUN
ajlm-429	26	55	samples	sample	NOUN
ajlm-429	26	56	drawn	draw	VERB
ajlm-429	26	57	into	into	ADP
ajlm-429	26	58	4.5	4.5	NUM
ajlm-429	26	59	ml	ml	X
ajlm-429	26	60	edta	edta	PROPN
ajlm-429	26	61	vacutainer	vacutainer	ADJ
ajlm-429	26	62	tubes	tube	NOUN
ajlm-429	26	63	,	,	PUNCT
ajlm-429	26	64	from	from	ADP
ajlm-429	26	65	which	which	PRON
ajlm-429	26	66	dbs	dbs	NOUN
ajlm-429	26	67	were	be	AUX
ajlm-429	26	68	produced	produce	VERB
ajlm-429	26	69	using	use	VERB
ajlm-429	26	70	whatman	whatman	NOUN
ajlm-429	26	71	ss903	ss903	PROPN
ajlm-429	26	72	specimen	specimen	PROPN
ajlm-429	26	73	collection	collection	NOUN
ajlm-429	26	74	paper	paper	NOUN
ajlm-429	26	75	,	,	PUNCT
ajlm-429	26	76	air	air	NOUN
ajlm-429	26	77	-	-	PUNCT
ajlm-429	26	78	dried	dry	VERB
ajlm-429	26	79	overnight	overnight	ADV
ajlm-429	26	80	in	in	ADP
ajlm-429	26	81	plastic	plastic	ADJ
ajlm-429	26	82	boxes	box	NOUN
ajlm-429	26	83	and	and	CCONJ
ajlm-429	26	84	stored	store	VERB
ajlm-429	26	85	in	in	ADP
ajlm-429	26	86	lots	lot	NOUN
ajlm-429	26	87	of	of	ADP
ajlm-429	26	88	20	20	NUM
ajlm-429	26	89	separated	separate	VERB
ajlm-429	26	90	by	by	ADP
ajlm-429	26	91	glassine	glassine	NOUN
ajlm-429	26	92	paper	paper	NOUN
ajlm-429	26	93	in	in	ADP
ajlm-429	26	94	ziploc	ziploc	NOUN
ajlm-429	26	95	bags	bag	NOUN
ajlm-429	26	96	containing	contain	VERB
ajlm-429	26	97	desiccants	desiccant	NOUN
ajlm-429	26	98	.	.	PUNCT
ajlm-429	27	1	in	in	ADP
ajlm-429	27	2	the	the	DET
ajlm-429	27	3	field	field	NOUN
ajlm-429	27	4	,	,	PUNCT
ajlm-429	27	5	blood	blood	NOUN
ajlm-429	27	6	was	be	AUX
ajlm-429	27	7	centrifuged	centrifuge	VERB
ajlm-429	27	8	and	and	CCONJ
ajlm-429	27	9	the	the	DET
ajlm-429	27	10	plasma	plasma	NOUN
ajlm-429	27	11	was	be	AUX
ajlm-429	27	12	transferred	transfer	VERB
ajlm-429	27	13	to	to	ADP
ajlm-429	27	14	microvials	microvial	NOUN
ajlm-429	27	15	.	.	PUNCT
ajlm-429	28	1	plasma	plasma	NOUN
ajlm-429	28	2	and	and	CCONJ
ajlm-429	28	3	dbs	dbs	NOUN
ajlm-429	28	4	were	be	AUX
ajlm-429	28	5	transported	transport	VERB
ajlm-429	28	6	periodically	periodically	ADV
ajlm-429	28	7	to	to	ADP
ajlm-429	28	8	a	a	DET
ajlm-429	28	9	central	central	ADJ
ajlm-429	28	10	laboratory	laboratory	NOUN
ajlm-429	28	11	in	in	ADP
ajlm-429	28	12	entebbe	entebbe	PROPN
ajlm-429	28	13	for	for	ADP
ajlm-429	28	14	processing	processing	NOUN
ajlm-429	28	15	and	and	CCONJ
ajlm-429	28	16	storage	storage	NOUN
ajlm-429	28	17	at	at	ADP
ajlm-429	28	18	-80	-80	NOUN
ajlm-429	28	19	°	°	ADP
ajlm-429	28	20	c	c	NOUN
ajlm-429	28	21	(	(	PUNCT
ajlm-429	28	22	plasma	plasma	NOUN
ajlm-429	28	23	)	)	PUNCT
ajlm-429	28	24	and	and	CCONJ
ajlm-429	28	25	-20	-20	NUM
ajlm-429	28	26	°	°	NUM
ajlm-429	28	27	c	c	NOUN
ajlm-429	28	28	(	(	PUNCT
ajlm-429	28	29	dbs	dbs	PROPN
ajlm-429	28	30	)	)	PUNCT
ajlm-429	28	31	.	.	PUNCT
ajlm-429	29	1	the	the	DET
ajlm-429	29	2	plasma	plasma	NOUN
ajlm-429	29	3	and	and	CCONJ
ajlm-429	29	4	dbs	dbs	NOUN
ajlm-429	29	5	samples	sample	NOUN
ajlm-429	29	6	for	for	ADP
ajlm-429	29	7	the	the	DET
ajlm-429	29	8	uhsbs	uhsbs	NOUN
ajlm-429	29	9	were	be	AUX
ajlm-429	29	10	tested	test	VERB
ajlm-429	29	11	for	for	ADP
ajlm-429	29	12	hsv-2	hsv-2	PRON
ajlm-429	29	13	antibodies	antibody	NOUN
ajlm-429	29	14	using	use	VERB
ajlm-429	29	15	the	the	DET
ajlm-429	29	16	kalon	kalon	PROPN
ajlm-429	29	17	elisa	elisa	PROPN
ajlm-429	29	18	hsv2	hsv2	PROPN
ajlm-429	29	19	assay	assay	VERB
ajlm-429	29	20	within	within	ADP
ajlm-429	29	21	several	several	ADJ
ajlm-429	29	22	weeks	week	NOUN
ajlm-429	29	23	of	of	ADP
ajlm-429	29	24	collection	collection	NOUN
ajlm-429	29	25	.	.	PUNCT
ajlm-429	30	1	results	result	NOUN
ajlm-429	30	2	were	be	AUX
ajlm-429	30	3	classified	classify	VERB
ajlm-429	30	4	as	as	ADP
ajlm-429	30	5	positive	positive	ADJ
ajlm-429	30	6	or	or	CCONJ
ajlm-429	30	7	negative	negative	ADJ
ajlm-429	30	8	using	use	VERB
ajlm-429	30	9	cutoffs	cutoff	NOUN
ajlm-429	30	10	as	as	SCONJ
ajlm-429	30	11	specified	specify	VERB
ajlm-429	30	12	by	by	ADP
ajlm-429	30	13	the	the	DET
ajlm-429	30	14	manufacturer	manufacturer	NOUN
ajlm-429	30	15	.	.	PUNCT
ajlm-429	31	1	dbs	dbs	PROPN
ajlm-429	31	2	validation	validation	NOUN
ajlm-429	31	3	study	study	NOUN
ajlm-429	31	4	design	design	NOUN
ajlm-429	31	5	for	for	ADP
ajlm-429	31	6	the	the	DET
ajlm-429	31	7	purposes	purpose	NOUN
ajlm-429	31	8	of	of	ADP
ajlm-429	31	9	this	this	DET
ajlm-429	31	10	study	study	NOUN
ajlm-429	31	11	,	,	PUNCT
ajlm-429	31	12	we	we	PRON
ajlm-429	31	13	randomly	randomly	ADV
ajlm-429	31	14	selected	select	VERB
ajlm-429	31	15	110	110	NUM
ajlm-429	31	16	stored	store	VERB
ajlm-429	31	17	dbs	dbs	NOUN
ajlm-429	31	18	specimens	specimen	NOUN
ajlm-429	31	19	from	from	ADP
ajlm-429	31	20	women	woman	NOUN
ajlm-429	31	21	aged	age	VERB
ajlm-429	31	22	18–24	18–24	NUM
ajlm-429	31	23	years	year	NOUN
ajlm-429	31	24	whose	whose	DET
ajlm-429	31	25	plasma	plasma	NOUN
ajlm-429	31	26	-	-	PUNCT
ajlm-429	31	27	based	base	VERB
ajlm-429	31	28	equivalents	equivalent	NOUN
ajlm-429	31	29	tested	test	VERB
ajlm-429	31	30	positive	positive	ADJ
ajlm-429	31	31	and	and	CCONJ
ajlm-429	31	32	110	110	NUM
ajlm-429	31	33	stored	store	VERB
ajlm-429	31	34	dbs	dbs	NOUN
ajlm-429	31	35	specimens	specimen	NOUN
ajlm-429	31	36	whose	whose	DET
ajlm-429	31	37	plasma	plasma	NOUN
ajlm-429	31	38	-	-	PUNCT
ajlm-429	31	39	based	base	VERB
ajlm-429	31	40	equivalents	equivalent	NOUN
ajlm-429	31	41	tested	test	VERB
ajlm-429	31	42	negative	negative	ADJ
ajlm-429	31	43	using	use	VERB
ajlm-429	31	44	the	the	DET
ajlm-429	31	45	kalon	kalon	PROPN
ajlm-429	31	46	elisa	elisa	PROPN
ajlm-429	31	47	hsv2	hsv2	PROPN
ajlm-429	31	48	assay	assay	PROPN
ajlm-429	31	49	.	.	PUNCT
ajlm-429	32	1	laboratory	laboratory	NOUN
ajlm-429	32	2	testing	testing	NOUN
ajlm-429	32	3	and	and	CCONJ
ajlm-429	32	4	analysis	analysis	NOUN
ajlm-429	32	5	was	be	AUX
ajlm-429	32	6	conducted	conduct	VERB
ajlm-429	32	7	at	at	ADP
ajlm-429	32	8	the	the	DET
ajlm-429	32	9	molecular	molecular	ADJ
ajlm-429	32	10	research	research	NOUN
ajlm-429	32	11	laboratory	laboratory	NOUN
ajlm-429	32	12	in	in	ADP
ajlm-429	32	13	kampala	kampala	PROPN
ajlm-429	32	14	as	as	ADP
ajlm-429	32	15	part	part	NOUN
ajlm-429	32	16	of	of	ADP
ajlm-429	32	17	the	the	DET
ajlm-429	32	18	makerere	makerere	ADJ
ajlm-429	32	19	university	university	NOUN
ajlm-429	32	20	-	-	PUNCT
ajlm-429	32	21	university	university	PROPN
ajlm-429	32	22	of	of	ADP
ajlm-429	32	23	california	california	PROPN
ajlm-429	32	24	,	,	PUNCT
ajlm-429	32	25	san	san	PROPN
ajlm-429	32	26	francisco	francisco	PROPN
ajlm-429	32	27	research	research	NOUN
ajlm-429	32	28	collaboration	collaboration	NOUN
ajlm-429	32	29	on	on	ADP
ajlm-429	32	30	2	2	NUM
ajlm-429	32	31	may	may	PROPN
ajlm-429	32	32	2011	2011	NUM
ajlm-429	32	33	.	.	PUNCT
ajlm-429	33	1	from	from	ADP
ajlm-429	33	2	each	each	PRON
ajlm-429	33	3	of	of	ADP
ajlm-429	33	4	these	these	DET
ajlm-429	33	5	220	220	NUM
ajlm-429	33	6	dbs	dbs	NOUN
ajlm-429	33	7	,	,	PUNCT
ajlm-429	33	8	a	a	DET
ajlm-429	33	9	6	6	NUM
ajlm-429	33	10	mm	mm	NOUN
ajlm-429	33	11	-	-	PUNCT
ajlm-429	33	12	diameter	diameter	NOUN
ajlm-429	33	13	(	(	PUNCT
ajlm-429	33	14	28	28	NUM
ajlm-429	33	15	mm2	mm2	NOUN
ajlm-429	33	16	)	)	PUNCT
ajlm-429	33	17	disk	disk	NOUN
ajlm-429	33	18	,	,	PUNCT
ajlm-429	33	19	containing	contain	VERB
ajlm-429	33	20	approximately	approximately	ADV
ajlm-429	33	21	50–75	50–75	NUM
ajlm-429	33	22	µl	µl	NOUN
ajlm-429	33	23	of	of	ADP
ajlm-429	33	24	blood	blood	NOUN
ajlm-429	33	25	per	per	ADP
ajlm-429	33	26	spot	spot	NOUN
ajlm-429	33	27	,	,	PUNCT
ajlm-429	33	28	was	be	AUX
ajlm-429	33	29	punched	punch	VERB
ajlm-429	33	30	out	out	ADP
ajlm-429	33	31	from	from	ADP
ajlm-429	33	32	the	the	DET
ajlm-429	33	33	filter	filter	NOUN
ajlm-429	33	34	paper	paper	NOUN
ajlm-429	33	35	and	and	CCONJ
ajlm-429	33	36	soaked	soak	VERB
ajlm-429	33	37	overnight	overnight	ADV
ajlm-429	33	38	at	at	ADP
ajlm-429	33	39	4	4	NUM
ajlm-429	33	40	°	°	NOUN
ajlm-429	33	41	c	c	NOUN
ajlm-429	33	42	in	in	ADP
ajlm-429	33	43	150	150	NUM
ajlm-429	33	44	µl	µl	NOUN
ajlm-429	33	45	of	of	ADP
ajlm-429	33	46	phosphate	phosphate	NOUN
ajlm-429	33	47	-	-	PUNCT
ajlm-429	33	48	buffered	buffer	VERB
ajlm-429	33	49	saline	saline	NOUN
ajlm-429	33	50	(	(	PUNCT
ajlm-429	33	51	ph	ph	NOUN
ajlm-429	33	52	7.4	7.4	NUM
ajlm-429	33	53	)	)	PUNCT
ajlm-429	33	54	.	.	PUNCT
ajlm-429	34	1	after	after	ADP
ajlm-429	34	2	the	the	DET
ajlm-429	34	3	overnight	overnight	ADJ
ajlm-429	34	4	elution	elution	NOUN
ajlm-429	34	5	step	step	NOUN
ajlm-429	34	6	,	,	PUNCT
ajlm-429	34	7	the	the	DET
ajlm-429	34	8	eluates	eluate	NOUN
ajlm-429	34	9	were	be	AUX
ajlm-429	34	10	diluted	dilute	VERB
ajlm-429	34	11	at	at	ADP
ajlm-429	34	12	three	three	NUM
ajlm-429	34	13	different	different	ADJ
ajlm-429	34	14	levels	level	NOUN
ajlm-429	34	15	,	,	PUNCT
ajlm-429	34	16	1:4	1:4	NUM
ajlm-429	34	17	,	,	PUNCT
ajlm-429	34	18	1:3	1:3	NUM
ajlm-429	34	19	and	and	CCONJ
ajlm-429	34	20	1:2	1:2	NUM
ajlm-429	34	21	.	.	PUNCT
ajlm-429	35	1	each	each	DET
ajlm-429	35	2	specimen	speciman	NOUN
ajlm-429	35	3	was	be	AUX
ajlm-429	35	4	tested	test	VERB
ajlm-429	35	5	in	in	ADP
ajlm-429	35	6	triplicate	triplicate	NOUN
ajlm-429	35	7	with	with	ADP
ajlm-429	35	8	the	the	DET
ajlm-429	35	9	kalon	kalon	PROPN
ajlm-429	35	10	elisa	elisa	PROPN
ajlm-429	35	11	hsv2	hsv2	PROPN
ajlm-429	35	12	assay	assay	PROPN
ajlm-429	35	13	,	,	PUNCT
ajlm-429	35	14	as	as	SCONJ
ajlm-429	35	15	directed	direct	VERB
ajlm-429	35	16	by	by	ADP
ajlm-429	35	17	the	the	DET
ajlm-429	35	18	manufacturer	manufacturer	NOUN
ajlm-429	35	19	’s	’s	PART
ajlm-429	35	20	instructions	instruction	NOUN
ajlm-429	35	21	.	.	PUNCT
ajlm-429	36	1	data	datum	NOUN
ajlm-429	36	2	analysis	analysis	NOUN
ajlm-429	36	3	frequencies	frequency	NOUN
ajlm-429	36	4	of	of	ADP
ajlm-429	36	5	reactivity	reactivity	NOUN
ajlm-429	36	6	,	,	PUNCT
ajlm-429	36	7	non	non	ADJ
ajlm-429	36	8	-	-	NOUN
ajlm-429	36	9	reactivity	reactivity	ADJ
ajlm-429	36	10	,	,	PUNCT
ajlm-429	36	11	sensitivity	sensitivity	NOUN
ajlm-429	36	12	and	and	CCONJ
ajlm-429	36	13	specificity	specificity	NOUN
ajlm-429	36	14	with	with	ADP
ajlm-429	36	15	95	95	NUM
ajlm-429	36	16	%	%	NOUN
ajlm-429	36	17	confidence	confidence	NOUN
ajlm-429	36	18	intervals	interval	NOUN
ajlm-429	36	19	were	be	AUX
ajlm-429	36	20	generated	generate	VERB
ajlm-429	36	21	using	use	VERB
ajlm-429	36	22	sas	sas	PROPN
ajlm-429	36	23	®	®	NOUN
ajlm-429	36	24	software	software	NOUN
ajlm-429	36	25	,	,	PUNCT
ajlm-429	36	26	version	version	NOUN
ajlm-429	36	27	9.3	9.3	NUM
ajlm-429	36	28	(	(	PUNCT
ajlm-429	36	29	sas	sas	PROPN
ajlm-429	36	30	institute	institute	PROPN
ajlm-429	36	31	inc	inc	PROPN
ajlm-429	36	32	.	.	PROPN
ajlm-429	36	33	,	,	PUNCT
ajlm-429	36	34	cary	cary	PROPN
ajlm-429	36	35	,	,	PUNCT
ajlm-429	36	36	north	north	PROPN
ajlm-429	36	37	carolina	carolina	PROPN
ajlm-429	36	38	,	,	PUNCT
ajlm-429	36	39	united	united	PROPN
ajlm-429	36	40	states	states	PROPN
ajlm-429	36	41	,	,	PUNCT
ajlm-429	36	42	2011	2011	NUM
ajlm-429	36	43	)	)	PUNCT
ajlm-429	36	44	.	.	PUNCT
ajlm-429	37	1	dbs	dbs	PROPN
ajlm-429	37	2	-	-	PUNCT
ajlm-429	37	3	based	base	VERB
ajlm-429	37	4	estimates	estimate	NOUN
ajlm-429	37	5	of	of	ADP
ajlm-429	37	6	sensitivity	sensitivity	NOUN
ajlm-429	37	7	and	and	CCONJ
ajlm-429	37	8	specificity	specificity	NOUN
ajlm-429	37	9	were	be	AUX
ajlm-429	37	10	obtained	obtain	VERB
ajlm-429	37	11	using	use	VERB
ajlm-429	37	12	the	the	DET
ajlm-429	37	13	plasma	plasma	NOUN
ajlm-429	37	14	-	-	PUNCT
ajlm-429	37	15	based	base	VERB
ajlm-429	37	16	results	result	NOUN
ajlm-429	37	17	as	as	ADP
ajlm-429	37	18	the	the	DET
ajlm-429	37	19	reference	reference	NOUN
ajlm-429	37	20	.	.	PUNCT
ajlm-429	38	1	we	we	PRON
ajlm-429	38	2	determined	determine	VERB
ajlm-429	38	3	the	the	DET
ajlm-429	38	4	dilution	dilution	NOUN
ajlm-429	38	5	level	level	NOUN
ajlm-429	38	6	for	for	ADP
ajlm-429	38	7	dbs	dbs	NOUN
ajlm-429	38	8	-	-	PUNCT
ajlm-429	38	9	based	base	VERB
ajlm-429	38	10	hsv-2	hsv-2	PUNCT
ajlm-429	38	11	testing	testing	NOUN
ajlm-429	38	12	that	that	PRON
ajlm-429	38	13	yielded	yield	VERB
ajlm-429	38	14	the	the	DET
ajlm-429	38	15	highest	high	ADJ
ajlm-429	38	16	(	(	PUNCT
ajlm-429	38	17	relative	relative	ADJ
ajlm-429	38	18	)	)	PUNCT
ajlm-429	38	19	sensitivity	sensitivity	NOUN
ajlm-429	38	20	and	and	CCONJ
ajlm-429	38	21	specificity	specificity	NOUN
ajlm-429	38	22	.	.	PUNCT
ajlm-429	39	1	results	result	VERB
ajlm-429	39	2	the	the	DET
ajlm-429	39	3	final	final	ADJ
ajlm-429	39	4	sample	sample	NOUN
ajlm-429	39	5	size	size	NOUN
ajlm-429	39	6	included	include	VERB
ajlm-429	39	7	210	210	NUM
ajlm-429	39	8	individuals	individual	NOUN
ajlm-429	39	9	due	due	ADJ
ajlm-429	39	10	to	to	ADP
ajlm-429	39	11	missing	miss	VERB
ajlm-429	39	12	test	test	NOUN
ajlm-429	39	13	results	result	NOUN
ajlm-429	39	14	for	for	ADP
ajlm-429	39	15	10	10	NUM
ajlm-429	39	16	dbs	dbs	NOUN
ajlm-429	39	17	.	.	PROPN
ajlm-429	40	1	of	of	ADP
ajlm-429	40	2	the	the	DET
ajlm-429	40	3	210	210	NUM
ajlm-429	40	4	plasma	plasma	NOUN
ajlm-429	40	5	specimens	specimen	NOUN
ajlm-429	40	6	,	,	PUNCT
ajlm-429	40	7	104	104	NUM
ajlm-429	40	8	(	(	PUNCT
ajlm-429	40	9	49.5	49.5	NUM
ajlm-429	40	10	%	%	NOUN
ajlm-429	40	11	)	)	PUNCT
ajlm-429	40	12	were	be	AUX
ajlm-429	40	13	reactive	reactive	ADJ
ajlm-429	40	14	and	and	CCONJ
ajlm-429	40	15	106	106	NUM
ajlm-429	40	16	(	(	PUNCT
ajlm-429	40	17	50.5	50.5	NUM
ajlm-429	40	18	%	%	NOUN
ajlm-429	40	19	)	)	PUNCT
ajlm-429	40	20	were	be	AUX
ajlm-429	40	21	non	non	ADJ
ajlm-429	40	22	-	-	ADJ
ajlm-429	40	23	reactive	reactive	ADJ
ajlm-429	40	24	for	for	ADP
ajlm-429	40	25	hsv-2	hsv-2	PRON
ajlm-429	40	26	antibodies	antibody	NOUN
ajlm-429	40	27	(	(	PUNCT
ajlm-429	40	28	table	table	NOUN
ajlm-429	40	29	1	1	NUM
ajlm-429	40	30	)	)	PUNCT
ajlm-429	40	31	.	.	PUNCT
ajlm-429	41	1	the	the	DET
ajlm-429	41	2	dbs	dbs	PROPN
ajlm-429	41	3	1:2	1:2	NUM
ajlm-429	41	4	dilution	dilution	NOUN
ajlm-429	41	5	yielded	yield	VERB
ajlm-429	41	6	116	116	NUM
ajlm-429	41	7	(	(	PUNCT
ajlm-429	41	8	55.2	55.2	NUM
ajlm-429	41	9	%	%	NOUN
ajlm-429	41	10	)	)	PUNCT
ajlm-429	41	11	reactive	reactive	NOUN
ajlm-429	41	12	and	and	CCONJ
ajlm-429	41	13	94	94	NUM
ajlm-429	41	14	(	(	PUNCT
ajlm-429	41	15	44.8	44.8	NUM
ajlm-429	41	16	%	%	NOUN
ajlm-429	41	17	)	)	PUNCT
ajlm-429	41	18	non	non	ADJ
ajlm-429	41	19	-	-	ADJ
ajlm-429	41	20	reactive	reactive	ADJ
ajlm-429	41	21	results	result	NOUN
ajlm-429	41	22	.	.	PUNCT
ajlm-429	42	1	dbs	dbs	PROPN
ajlm-429	42	2	1:3	1:3	NUM
ajlm-429	42	3	produced	produce	VERB
ajlm-429	42	4	124	124	NUM
ajlm-429	42	5	(	(	PUNCT
ajlm-429	42	6	59.0	59.0	NUM
ajlm-429	42	7	%	%	NOUN
ajlm-429	42	8	)	)	PUNCT
ajlm-429	42	9	reactive	reactive	NOUN
ajlm-429	42	10	and	and	CCONJ
ajlm-429	42	11	86	86	NUM
ajlm-429	42	12	(	(	PUNCT
ajlm-429	42	13	41.0	41.0	NUM
ajlm-429	42	14	%	%	NOUN
ajlm-429	42	15	)	)	PUNCT
ajlm-429	42	16	non	non	ADJ
ajlm-429	42	17	-	-	ADJ
ajlm-429	42	18	reactive	reactive	ADJ
ajlm-429	42	19	results	result	NOUN
ajlm-429	42	20	,	,	PUNCT
ajlm-429	42	21	whereas	whereas	SCONJ
ajlm-429	42	22	dbs	dbs	PROPN
ajlm-429	42	23	1:4	1:4	NUM
ajlm-429	42	24	yielded	yield	VERB
ajlm-429	42	25	110	110	NUM
ajlm-429	42	26	(	(	PUNCT
ajlm-429	42	27	52.4	52.4	NUM
ajlm-429	42	28	%	%	NOUN
ajlm-429	42	29	)	)	PUNCT
ajlm-429	42	30	reactive	reactive	NOUN
ajlm-429	42	31	and	and	CCONJ
ajlm-429	42	32	100	100	NUM
ajlm-429	42	33	(	(	PUNCT
ajlm-429	42	34	47.6	47.6	NUM
ajlm-429	42	35	%	%	NOUN
ajlm-429	42	36	)	)	PUNCT
ajlm-429	42	37	non	non	ADJ
ajlm-429	42	38	-	-	ADJ
ajlm-429	42	39	reactive	reactive	ADJ
ajlm-429	42	40	results	result	NOUN
ajlm-429	42	41	.	.	PUNCT
ajlm-429	43	1	table	table	NOUN
ajlm-429	43	2	1	1	NUM
ajlm-429	43	3	:	:	PUNCT
ajlm-429	43	4	 	 	SPACE
ajlm-429	43	5	hsv-2	hsv-2	PART
ajlm-429	43	6	seropositivity	seropositivity	NOUN
ajlm-429	43	7	for	for	ADP
ajlm-429	43	8	plasma	plasma	NOUN
ajlm-429	43	9	-	-	PUNCT
ajlm-429	43	10	based	base	VERB
ajlm-429	43	11	and	and	CCONJ
ajlm-429	43	12	dbs	dbs	PROPN
ajlm-429	43	13	dilution	dilution	NOUN
ajlm-429	43	14	-	-	PUNCT
ajlm-429	43	15	based	base	VERB
ajlm-429	43	16	assays	assay	NOUN
ajlm-429	43	17	using	use	VERB
ajlm-429	43	18	the	the	DET
ajlm-429	43	19	kalon	kalon	PROPN
ajlm-429	43	20	elisa	elisa	PROPN
ajlm-429	43	21	hsv2	hsv2	PROPN
ajlm-429	43	22	assay	assay	PROPN
ajlm-429	43	23	among	among	ADP
ajlm-429	43	24	young	young	ADJ
ajlm-429	43	25	women	woman	NOUN
ajlm-429	43	26	in	in	ADP
ajlm-429	43	27	uganda	uganda	PROPN
ajlm-429	43	28	,	,	PUNCT
ajlm-429	43	29	2004–2005.†	2004–2005.†	NUM
ajlm-429	43	30	the	the	DET
ajlm-429	43	31	1:2	1:2	NUM
ajlm-429	43	32	ratio	ratio	NOUN
ajlm-429	43	33	of	of	ADP
ajlm-429	43	34	buffer	buffer	NOUN
ajlm-429	43	35	and	and	CCONJ
ajlm-429	43	36	eluate	eluate	ADJ
ajlm-429	43	37	yielded	yield	VERB
ajlm-429	43	38	the	the	DET
ajlm-429	43	39	highest	high	ADJ
ajlm-429	43	40	sensitivity	sensitivity	NOUN
ajlm-429	43	41	(	(	PUNCT
ajlm-429	43	42	84.6	84.6	NUM
ajlm-429	43	43	%	%	NOUN
ajlm-429	43	44	)	)	PUNCT
ajlm-429	43	45	and	and	CCONJ
ajlm-429	43	46	specificity	specificity	NOUN
ajlm-429	43	47	(	(	PUNCT
ajlm-429	43	48	73.6	73.6	NUM
ajlm-429	43	49	%	%	NOUN
ajlm-429	43	50	)	)	PUNCT
ajlm-429	43	51	(	(	PUNCT
ajlm-429	43	52	table	table	NOUN
ajlm-429	43	53	2	2	NUM
ajlm-429	43	54	)	)	PUNCT
ajlm-429	43	55	.	.	PUNCT
ajlm-429	44	1	the	the	DET
ajlm-429	44	2	1:3	1:3	NUM
ajlm-429	44	3	dilution	dilution	NOUN
ajlm-429	44	4	had	have	VERB
ajlm-429	44	5	the	the	DET
ajlm-429	44	6	next	next	ADJ
ajlm-429	44	7	-	-	PUNCT
ajlm-429	44	8	highest	high	ADJ
ajlm-429	44	9	sensitivity	sensitivity	NOUN
ajlm-429	44	10	(	(	PUNCT
ajlm-429	44	11	82.7	82.7	NUM
ajlm-429	44	12	%	%	NOUN
ajlm-429	44	13	)	)	PUNCT
ajlm-429	44	14	,	,	PUNCT
ajlm-429	44	15	but	but	CCONJ
ajlm-429	44	16	had	have	VERB
ajlm-429	44	17	the	the	DET
ajlm-429	44	18	lowest	low	ADJ
ajlm-429	44	19	specificity	specificity	NOUN
ajlm-429	44	20	(	(	PUNCT
ajlm-429	44	21	64.2	64.2	NUM
ajlm-429	44	22	%	%	NOUN
ajlm-429	44	23	)	)	PUNCT
ajlm-429	44	24	.	.	PUNCT
ajlm-429	45	1	the	the	DET
ajlm-429	45	2	1:4	1:4	NUM
ajlm-429	45	3	dilution	dilution	NOUN
ajlm-429	45	4	showed	show	VERB
ajlm-429	45	5	the	the	DET
ajlm-429	45	6	lowest	low	ADJ
ajlm-429	45	7	sensitivity	sensitivity	NOUN
ajlm-429	45	8	(	(	PUNCT
ajlm-429	45	9	73.1	73.1	NUM
ajlm-429	45	10	%	%	NOUN
ajlm-429	45	11	)	)	PUNCT
ajlm-429	45	12	and	and	CCONJ
ajlm-429	45	13	a	a	DET
ajlm-429	45	14	specificity	specificity	NOUN
ajlm-429	45	15	of	of	ADP
ajlm-429	45	16	67.9	67.9	NUM
ajlm-429	45	17	%	%	NOUN
ajlm-429	45	18	.	.	PUNCT
ajlm-429	46	1	overall	overall	ADJ
ajlm-429	46	2	,	,	PUNCT
ajlm-429	46	3	127	127	NUM
ajlm-429	46	4	(	(	PUNCT
ajlm-429	46	5	60.5	60.5	NUM
ajlm-429	46	6	%	%	NOUN
ajlm-429	46	7	)	)	PUNCT
ajlm-429	46	8	of	of	ADP
ajlm-429	46	9	the	the	DET
ajlm-429	46	10	210	210	NUM
ajlm-429	46	11	specimens	specimen	NOUN
ajlm-429	46	12	had	have	VERB
ajlm-429	46	13	concordant	concordant	ADJ
ajlm-429	46	14	results	result	NOUN
ajlm-429	46	15	between	between	ADP
ajlm-429	46	16	plasma	plasma	NOUN
ajlm-429	46	17	and	and	CCONJ
ajlm-429	46	18	all	all	DET
ajlm-429	46	19	three	three	NUM
ajlm-429	46	20	dbs	dbs	NOUN
ajlm-429	46	21	dilutions	dilution	NOUN
ajlm-429	46	22	(	(	PUNCT
ajlm-429	46	23	not	not	PART
ajlm-429	46	24	shown	show	VERB
ajlm-429	46	25	in	in	ADP
ajlm-429	46	26	the	the	DET
ajlm-429	46	27	tables	table	NOUN
ajlm-429	46	28	)	)	PUNCT
ajlm-429	46	29	.	.	PUNCT
ajlm-429	47	1	of	of	ADP
ajlm-429	47	2	the	the	DET
ajlm-429	47	3	127	127	NUM
ajlm-429	47	4	concordant	concordant	ADJ
ajlm-429	47	5	results	result	NOUN
ajlm-429	47	6	,	,	PUNCT
ajlm-429	47	7	69	69	NUM
ajlm-429	47	8	(	(	PUNCT
ajlm-429	47	9	54.3	54.3	NUM
ajlm-429	47	10	%	%	NOUN
ajlm-429	47	11	)	)	PUNCT
ajlm-429	47	12	were	be	AUX
ajlm-429	47	13	concordant	concordant	ADJ
ajlm-429	47	14	positive	positive	ADJ
ajlm-429	47	15	and	and	CCONJ
ajlm-429	47	16	58	58	NUM
ajlm-429	47	17	(	(	PUNCT
ajlm-429	47	18	45.7	45.7	NUM
ajlm-429	47	19	%	%	NOUN
ajlm-429	47	20	)	)	PUNCT
ajlm-429	47	21	were	be	AUX
ajlm-429	47	22	concordant	concordant	ADJ
ajlm-429	47	23	negative	negative	ADJ
ajlm-429	47	24	.	.	PUNCT
ajlm-429	48	1	a	a	DET
ajlm-429	48	2	total	total	NOUN
ajlm-429	48	3	of	of	ADP
ajlm-429	48	4	83	83	NUM
ajlm-429	48	5	(	(	PUNCT
ajlm-429	48	6	39.5	39.5	NUM
ajlm-429	48	7	%	%	NOUN
ajlm-429	48	8	)	)	PUNCT
ajlm-429	48	9	cases	case	NOUN
ajlm-429	48	10	had	have	VERB
ajlm-429	48	11	a	a	DET
ajlm-429	48	12	discordant	discordant	ADJ
ajlm-429	48	13	result	result	NOUN
ajlm-429	48	14	between	between	ADP
ajlm-429	48	15	plasma	plasma	NOUN
ajlm-429	48	16	and	and	CCONJ
ajlm-429	48	17	at	at	ADP
ajlm-429	48	18	least	least	ADJ
ajlm-429	48	19	one	one	NUM
ajlm-429	48	20	of	of	ADP
ajlm-429	48	21	the	the	DET
ajlm-429	48	22	dbs	dbs	PROPN
ajlm-429	48	23	dilutions	dilution	NOUN
ajlm-429	48	24	.	.	PUNCT
ajlm-429	49	1	of	of	ADP
ajlm-429	49	2	the	the	DET
ajlm-429	49	3	83	83	NUM
ajlm-429	49	4	discordant	discordant	ADJ
ajlm-429	49	5	results	result	NOUN
ajlm-429	49	6	,	,	PUNCT
ajlm-429	49	7	35	35	NUM
ajlm-429	49	8	(	(	PUNCT
ajlm-429	49	9	42.2	42.2	NUM
ajlm-429	49	10	%	%	NOUN
ajlm-429	49	11	)	)	PUNCT
ajlm-429	49	12	were	be	AUX
ajlm-429	49	13	discordant	discordant	ADJ
ajlm-429	49	14	positive	positive	ADJ
ajlm-429	49	15	and	and	CCONJ
ajlm-429	49	16	48	48	NUM
ajlm-429	49	17	(	(	PUNCT
ajlm-429	49	18	57.8	57.8	NUM
ajlm-429	49	19	%	%	NOUN
ajlm-429	49	20	)	)	PUNCT
ajlm-429	49	21	were	be	AUX
ajlm-429	49	22	discordant	discordant	ADJ
ajlm-429	49	23	negative	negative	ADJ
ajlm-429	49	24	.	.	PUNCT
ajlm-429	50	1	table	table	NOUN
ajlm-429	50	2	2	2	NUM
ajlm-429	50	3	:	:	PUNCT
ajlm-429	50	4	 	 	SPACE
ajlm-429	50	5	relative	relative	ADJ
ajlm-429	50	6	sensitivity	sensitivity	NOUN
ajlm-429	50	7	,	,	PUNCT
ajlm-429	50	8	specificity	specificity	NOUN
ajlm-429	50	9	and	and	CCONJ
ajlm-429	50	10	95	95	NUM
ajlm-429	50	11	%	%	NOUN
ajlm-429	50	12	confidence	confidence	NOUN
ajlm-429	50	13	intervals	interval	NOUN
ajlm-429	50	14	of	of	ADP
ajlm-429	50	15	dried	dry	VERB
ajlm-429	50	16	bloodspot	bloodspot	NOUN
ajlm-429	50	17	dilutions	dilution	NOUN
ajlm-429	50	18	tested	test	VERB
ajlm-429	50	19	with	with	ADP
ajlm-429	50	20	the	the	DET
ajlm-429	50	21	kalon	kalon	PROPN
ajlm-429	50	22	elisa	elisa	PROPN
ajlm-429	50	23	hsv2	hsv2	PROPN
ajlm-429	50	24	assay	assay	PROPN
ajlm-429	50	25	compared	compare	VERB
ajlm-429	50	26	with	with	ADP
ajlm-429	50	27	plasma	plasma	NOUN
ajlm-429	50	28	among	among	ADP
ajlm-429	50	29	young	young	ADJ
ajlm-429	50	30	women	woman	NOUN
ajlm-429	50	31	in	in	ADP
ajlm-429	50	32	uganda	uganda	PROPN
ajlm-429	50	33	,	,	PUNCT
ajlm-429	50	34	2004–2005.†	2004–2005.†	NUM
ajlm-429	50	35	discussion	discussion	NOUN
ajlm-429	50	36	the	the	DET
ajlm-429	50	37	kalon	kalon	PROPN
ajlm-429	50	38	elisa	elisa	PROPN
ajlm-429	50	39	hsv2	hsv2	PROPN
ajlm-429	50	40	assay	assay	PROPN
ajlm-429	50	41	has	have	AUX
ajlm-429	50	42	been	be	AUX
ajlm-429	50	43	shown	show	VERB
ajlm-429	50	44	to	to	PART
ajlm-429	50	45	be	be	AUX
ajlm-429	50	46	sensitive	sensitive	ADJ
ajlm-429	50	47	and	and	CCONJ
ajlm-429	50	48	specific	specific	ADJ
ajlm-429	50	49	for	for	ADP
ajlm-429	50	50	hsv-2	hsv-2	PRON
ajlm-429	50	51	diagnosis	diagnosis	NOUN
ajlm-429	50	52	using	use	VERB
ajlm-429	50	53	plasma.2,12	plasma.2,12	PROPN
ajlm-429	50	54	in	in	ADP
ajlm-429	50	55	our	our	PRON
ajlm-429	50	56	study	study	NOUN
ajlm-429	50	57	,	,	PUNCT
ajlm-429	50	58	a	a	DET
ajlm-429	50	59	dilution	dilution	NOUN
ajlm-429	50	60	of	of	ADP
ajlm-429	50	61	1:2	1:2	NUM
ajlm-429	50	62	showed	show	VERB
ajlm-429	50	63	the	the	DET
ajlm-429	50	64	highest	high	ADJ
ajlm-429	50	65	sensitivity	sensitivity	NOUN
ajlm-429	50	66	and	and	CCONJ
ajlm-429	50	67	specificity	specificity	NOUN
ajlm-429	50	68	compared	compare	VERB
ajlm-429	50	69	with	with	ADP
ajlm-429	50	70	the	the	DET
ajlm-429	50	71	1:3	1:3	NUM
ajlm-429	50	72	and	and	CCONJ
ajlm-429	50	73	1:4	1:4	NUM
ajlm-429	50	74	dilution	dilution	NOUN
ajlm-429	50	75	levels	level	NOUN
ajlm-429	50	76	.	.	PUNCT
ajlm-429	51	1	this	this	DET
ajlm-429	51	2	estimated	estimate	VERB
ajlm-429	51	3	sensitivity	sensitivity	NOUN
ajlm-429	51	4	and	and	CCONJ
ajlm-429	51	5	specificity	specificity	NOUN
ajlm-429	51	6	is	be	AUX
ajlm-429	51	7	low	low	ADJ
ajlm-429	51	8	relative	relative	ADJ
ajlm-429	51	9	to	to	ADP
ajlm-429	51	10	the	the	DET
ajlm-429	51	11	plasma	plasma	NOUN
ajlm-429	51	12	-	-	PUNCT
ajlm-429	51	13	based	base	VERB
ajlm-429	51	14	reference	reference	NOUN
ajlm-429	51	15	results	result	VERB
ajlm-429	51	16	.	.	PUNCT
ajlm-429	52	1	specifically	specifically	ADV
ajlm-429	52	2	,	,	PUNCT
ajlm-429	52	3	our	our	PRON
ajlm-429	52	4	findings	finding	NOUN
ajlm-429	52	5	differ	differ	VERB
ajlm-429	52	6	from	from	ADP
ajlm-429	52	7	the	the	DET
ajlm-429	52	8	estimated	estimate	VERB
ajlm-429	52	9	higher	high	ADJ
ajlm-429	52	10	sensitivity	sensitivity	NOUN
ajlm-429	52	11	and	and	CCONJ
ajlm-429	52	12	specificity	specificity	NOUN
ajlm-429	52	13	found	find	VERB
ajlm-429	52	14	in	in	ADP
ajlm-429	52	15	a	a	DET
ajlm-429	52	16	south	south	ADJ
ajlm-429	52	17	african	african	ADJ
ajlm-429	52	18	population	population	NOUN
ajlm-429	52	19	which	which	PRON
ajlm-429	52	20	used	use	VERB
ajlm-429	52	21	the	the	DET
ajlm-429	52	22	herpeselect	herpeselect	ADJ
ajlm-429	52	23	elisa	elisa	NOUN
ajlm-429	52	24	serological	serological	ADJ
ajlm-429	52	25	assay.13	assay.13	NOUN
ajlm-429	52	26	however	however	ADV
ajlm-429	52	27	,	,	PUNCT
ajlm-429	52	28	earlier	early	ADJ
ajlm-429	52	29	studies	study	NOUN
ajlm-429	52	30	evaluating	evaluate	VERB
ajlm-429	52	31	the	the	DET
ajlm-429	52	32	plasma	plasma	NOUN
ajlm-429	52	33	-	-	PUNCT
ajlm-429	52	34	based	base	VERB
ajlm-429	52	35	herpeselect	herpeselect	PROPN
ajlm-429	52	36	elisa	elisa	PROPN
ajlm-429	52	37	test	test	NOUN
ajlm-429	52	38	in	in	ADP
ajlm-429	52	39	sub	sub	ADJ
ajlm-429	52	40	-	-	ADJ
ajlm-429	52	41	saharan	saharan	ADJ
ajlm-429	52	42	populations	population	NOUN
ajlm-429	52	43	suggested	suggest	VERB
ajlm-429	52	44	a	a	DET
ajlm-429	52	45	lower	low	ADJ
ajlm-429	52	46	specificity	specificity	NOUN
ajlm-429	52	47	than	than	ADP
ajlm-429	52	48	the	the	DET
ajlm-429	52	49	plasma	plasma	NOUN
ajlm-429	52	50	-	-	PUNCT
ajlm-429	52	51	based	base	VERB
ajlm-429	52	52	kalon	kalon	PROPN
ajlm-429	52	53	elisa	elisa	PROPN
ajlm-429	52	54	hsv2	hsv2	PROPN
ajlm-429	52	55	assay.14	assay.14	PROPN
ajlm-429	52	56	in	in	ADP
ajlm-429	52	57	addition	addition	NOUN
ajlm-429	52	58	,	,	PUNCT
ajlm-429	52	59	patterns	pattern	NOUN
ajlm-429	52	60	of	of	ADP
ajlm-429	52	61	reactivity	reactivity	NOUN
ajlm-429	52	62	varied	vary	VERB
ajlm-429	52	63	by	by	ADP
ajlm-429	52	64	dilution	dilution	NOUN
ajlm-429	52	65	level	level	NOUN
ajlm-429	52	66	.	.	PUNCT
ajlm-429	53	1	although	although	SCONJ
ajlm-429	53	2	not	not	PART
ajlm-429	53	3	the	the	DET
ajlm-429	53	4	optimal	optimal	ADJ
ajlm-429	53	5	dilution	dilution	NOUN
ajlm-429	53	6	based	base	VERB
ajlm-429	53	7	on	on	ADP
ajlm-429	53	8	sensitivity	sensitivity	NOUN
ajlm-429	53	9	or	or	CCONJ
ajlm-429	53	10	specificity	specificity	NOUN
ajlm-429	53	11	,	,	PUNCT
ajlm-429	53	12	dbs	dbs	PROPN
ajlm-429	53	13	1:3	1:3	NUM
ajlm-429	53	14	had	have	VERB
ajlm-429	53	15	the	the	DET
ajlm-429	53	16	highest	high	ADJ
ajlm-429	53	17	proportional	proportional	ADJ
ajlm-429	53	18	reactivity	reactivity	NOUN
ajlm-429	53	19	to	to	ADP
ajlm-429	53	20	hsv-2	hsv-2	X
ajlm-429	53	21	antibodies	antibody	NOUN
ajlm-429	53	22	(	(	PUNCT
ajlm-429	53	23	59.0	59.0	NUM
ajlm-429	53	24	%	%	NOUN
ajlm-429	53	25	)	)	PUNCT
ajlm-429	53	26	.	.	PUNCT
ajlm-429	54	1	all	all	DET
ajlm-429	54	2	three	three	NUM
ajlm-429	54	3	dilutions	dilution	NOUN
ajlm-429	54	4	yielded	yield	VERB
ajlm-429	54	5	higher	high	ADJ
ajlm-429	54	6	frequencies	frequency	NOUN
ajlm-429	54	7	of	of	ADP
ajlm-429	54	8	reactivity	reactivity	NOUN
ajlm-429	54	9	than	than	ADP
ajlm-429	54	10	plasma	plasma	NOUN
ajlm-429	54	11	(	(	PUNCT
ajlm-429	54	12	49.5	49.5	NUM
ajlm-429	54	13	%	%	NOUN
ajlm-429	54	14	)	)	PUNCT
ajlm-429	54	15	,	,	PUNCT
ajlm-429	54	16	specifically	specifically	ADV
ajlm-429	54	17	dbs	dbs	PROPN
ajlm-429	54	18	1:2	1:2	NUM
ajlm-429	54	19	(	(	PUNCT
ajlm-429	54	20	55.2	55.2	NUM
ajlm-429	54	21	%	%	NOUN
ajlm-429	54	22	)	)	PUNCT
ajlm-429	54	23	,	,	PUNCT
ajlm-429	54	24	dbs	dbs	PROPN
ajlm-429	54	25	1:3	1:3	NUM
ajlm-429	54	26	(	(	PUNCT
ajlm-429	54	27	59.0	59.0	NUM
ajlm-429	54	28	%	%	NOUN
ajlm-429	54	29	)	)	PUNCT
ajlm-429	54	30	and	and	CCONJ
ajlm-429	54	31	dbs	dbs	PROPN
ajlm-429	54	32	1:4	1:4	NUM
ajlm-429	54	33	(	(	PUNCT
ajlm-429	54	34	52.4	52.4	NUM
ajlm-429	54	35	%	%	NOUN
ajlm-429	54	36	)	)	PUNCT
ajlm-429	54	37	.	.	PUNCT
ajlm-429	55	1	we	we	PRON
ajlm-429	55	2	found	find	VERB
ajlm-429	55	3	low	low	ADJ
ajlm-429	55	4	concordance	concordance	NOUN
ajlm-429	55	5	between	between	ADP
ajlm-429	55	6	plasma	plasma	NOUN
ajlm-429	55	7	-	-	PUNCT
ajlm-429	55	8	based	base	VERB
ajlm-429	55	9	and	and	CCONJ
ajlm-429	55	10	dbs	dbs	ADV
ajlm-429	55	11	-	-	PUNCT
ajlm-429	55	12	based	base	VERB
ajlm-429	55	13	results	result	NOUN
ajlm-429	55	14	,	,	PUNCT
ajlm-429	55	15	which	which	PRON
ajlm-429	55	16	contrasts	contrast	VERB
ajlm-429	55	17	with	with	ADP
ajlm-429	55	18	the	the	DET
ajlm-429	55	19	high	high	ADJ
ajlm-429	55	20	concordance	concordance	NOUN
ajlm-429	55	21	reported	report	VERB
ajlm-429	55	22	by	by	ADP
ajlm-429	55	23	hogrefe	hogrefe	PROPN
ajlm-429	55	24	et	et	PROPN
ajlm-429	55	25	al	al	PROPN
ajlm-429	55	26	.	.	PUNCT
ajlm-429	55	27	using	use	VERB
ajlm-429	55	28	the	the	DET
ajlm-429	55	29	herpeselect	herpeselect	NOUN
ajlm-429	55	30	assay.10	assay.10	NOUN
ajlm-429	55	31	limitations	limitation	NOUN
ajlm-429	55	32	there	there	PRON
ajlm-429	55	33	are	be	VERB
ajlm-429	55	34	several	several	ADJ
ajlm-429	55	35	limitations	limitation	NOUN
ajlm-429	55	36	in	in	ADP
ajlm-429	55	37	our	our	PRON
ajlm-429	55	38	study	study	NOUN
ajlm-429	55	39	.	.	PUNCT
ajlm-429	56	1	the	the	DET
ajlm-429	56	2	sampling	sample	VERB
ajlm-429	56	3	frame	frame	NOUN
ajlm-429	56	4	was	be	AUX
ajlm-429	56	5	limited	limit	VERB
ajlm-429	56	6	to	to	ADP
ajlm-429	56	7	young	young	ADJ
ajlm-429	56	8	women	woman	NOUN
ajlm-429	56	9	aged	age	VERB
ajlm-429	56	10	18–24	18–24	NUM
ajlm-429	56	11	years	year	NOUN
ajlm-429	56	12	in	in	ADP
ajlm-429	56	13	uganda	uganda	PROPN
ajlm-429	56	14	;	;	PUNCT
ajlm-429	56	15	thus	thus	ADV
ajlm-429	56	16	,	,	PUNCT
ajlm-429	56	17	our	our	PRON
ajlm-429	56	18	results	result	NOUN
ajlm-429	56	19	are	be	AUX
ajlm-429	56	20	not	not	PART
ajlm-429	56	21	generalisable	generalisable	ADJ
ajlm-429	56	22	to	to	ADP
ajlm-429	56	23	men	man	NOUN
ajlm-429	56	24	or	or	CCONJ
ajlm-429	56	25	older	old	ADJ
ajlm-429	56	26	adults	adult	NOUN
ajlm-429	56	27	.	.	PUNCT
ajlm-429	57	1	additionally	additionally	ADV
ajlm-429	57	2	,	,	PUNCT
ajlm-429	57	3	the	the	DET
ajlm-429	57	4	sample	sample	NOUN
ajlm-429	57	5	size	size	NOUN
ajlm-429	57	6	was	be	AUX
ajlm-429	57	7	relatively	relatively	ADV
ajlm-429	57	8	small	small	ADJ
ajlm-429	57	9	.	.	PUNCT
ajlm-429	58	1	further	far	ADV
ajlm-429	58	2	,	,	PUNCT
ajlm-429	58	3	we	we	PRON
ajlm-429	58	4	did	do	AUX
ajlm-429	58	5	not	not	PART
ajlm-429	58	6	compare	compare	VERB
ajlm-429	58	7	the	the	DET
ajlm-429	58	8	quantity	quantity	NOUN
ajlm-429	58	9	of	of	ADP
ajlm-429	58	10	igg	igg	PROPN
ajlm-429	58	11	in	in	ADP
ajlm-429	58	12	the	the	DET
ajlm-429	58	13	dbs	dbs	PROPN
ajlm-429	58	14	punch	punch	NOUN
ajlm-429	58	15	specimens	specimen	NOUN
ajlm-429	58	16	to	to	ADP
ajlm-429	58	17	that	that	PRON
ajlm-429	58	18	in	in	ADP
ajlm-429	58	19	plasma	plasma	NOUN
ajlm-429	58	20	specimens	specimen	NOUN
ajlm-429	58	21	.	.	PUNCT
ajlm-429	59	1	finally	finally	ADV
ajlm-429	59	2	,	,	PUNCT
ajlm-429	59	3	this	this	DET
ajlm-429	59	4	study	study	NOUN
ajlm-429	59	5	only	only	ADV
ajlm-429	59	6	used	use	VERB
ajlm-429	59	7	the	the	DET
ajlm-429	59	8	kalon	kalon	PROPN
ajlm-429	59	9	elisa	elisa	PROPN
ajlm-429	59	10	hsv2	hsv2	PROPN
ajlm-429	59	11	assay	assay	PROPN
ajlm-429	59	12	to	to	PART
ajlm-429	59	13	evaluate	evaluate	VERB
ajlm-429	59	14	dbs	dbs	NOUN
ajlm-429	59	15	for	for	ADP
ajlm-429	59	16	hsv-2	hsv-2	DET
ajlm-429	59	17	diagnosis	diagnosis	NOUN
ajlm-429	59	18	.	.	PUNCT
ajlm-429	60	1	other	other	ADJ
ajlm-429	60	2	hsv-2	hsv-2	ADP
ajlm-429	60	3	assays	assay	NOUN
ajlm-429	60	4	,	,	PUNCT
ajlm-429	60	5	such	such	ADJ
ajlm-429	60	6	as	as	ADP
ajlm-429	60	7	the	the	DET
ajlm-429	60	8	herpeselect	herpeselect	ADJ
ajlm-429	60	9	2	2	NUM
ajlm-429	60	10	elisa	elisa	X
ajlm-429	60	11	igg	igg	PROPN
ajlm-429	60	12	and	and	CCONJ
ajlm-429	60	13	biokit	biokit	PROPN
ajlm-429	60	14	hsv2	hsv2	PROPN
ajlm-429	60	15	rapid	rapid	ADJ
ajlm-429	60	16	assay	assay	NOUN
ajlm-429	60	17	are	be	AUX
ajlm-429	60	18	used	use	VERB
ajlm-429	60	19	in	in	ADP
ajlm-429	60	20	african	african	ADJ
ajlm-429	60	21	countries	country	NOUN
ajlm-429	60	22	and	and	CCONJ
ajlm-429	60	23	need	need	VERB
ajlm-429	60	24	to	to	PART
ajlm-429	60	25	be	be	AUX
ajlm-429	60	26	further	far	ADV
ajlm-429	60	27	evaluated	evaluate	VERB
ajlm-429	60	28	to	to	PART
ajlm-429	60	29	compare	compare	VERB
ajlm-429	60	30	their	their	PRON
ajlm-429	60	31	utility	utility	NOUN
ajlm-429	60	32	with	with	ADP
ajlm-429	60	33	dbs	dbs	PROPN
ajlm-429	60	34	.	.	PROPN
ajlm-429	60	35	conclusion	conclusion	NOUN
ajlm-429	60	36	in	in	ADP
ajlm-429	60	37	summary	summary	NOUN
ajlm-429	60	38	,	,	PUNCT
ajlm-429	60	39	our	our	PRON
ajlm-429	60	40	study	study	NOUN
ajlm-429	60	41	examined	examine	VERB
ajlm-429	60	42	the	the	DET
ajlm-429	60	43	performance	performance	NOUN
ajlm-429	60	44	of	of	ADP
ajlm-429	60	45	the	the	DET
ajlm-429	60	46	kalon	kalon	PROPN
ajlm-429	60	47	elisa	elisa	PROPN
ajlm-429	60	48	hsv2	hsv2	PROPN
ajlm-429	60	49	assay	assay	PROPN
ajlm-429	60	50	,	,	PUNCT
ajlm-429	60	51	using	use	VERB
ajlm-429	60	52	dbs	dbs	NOUN
ajlm-429	60	53	in	in	ADP
ajlm-429	60	54	a	a	DET
ajlm-429	60	55	population	population	NOUN
ajlm-429	60	56	of	of	ADP
ajlm-429	60	57	young	young	ADJ
ajlm-429	60	58	women	woman	NOUN
ajlm-429	60	59	in	in	ADP
ajlm-429	60	60	uganda	uganda	PROPN
ajlm-429	60	61	.	.	PUNCT
ajlm-429	61	1	dbs	dbs	PROPN
ajlm-429	61	2	testing	test	VERB
ajlm-429	61	3	with	with	ADP
ajlm-429	61	4	the	the	DET
ajlm-429	61	5	kalon	kalon	PROPN
ajlm-429	61	6	elisa	elisa	PROPN
ajlm-429	61	7	hsv2	hsv2	PROPN
ajlm-429	61	8	assay	assay	PROPN
ajlm-429	61	9	revealed	reveal	VERB
ajlm-429	61	10	relatively	relatively	ADV
ajlm-429	61	11	low	low	ADJ
ajlm-429	61	12	sensitivity	sensitivity	NOUN
ajlm-429	61	13	and	and	CCONJ
ajlm-429	61	14	specificity	specificity	NOUN
ajlm-429	61	15	compared	compare	VERB
ajlm-429	61	16	with	with	ADP
ajlm-429	61	17	plasma	plasma	NOUN
ajlm-429	61	18	-	-	PUNCT
ajlm-429	61	19	based	base	VERB
ajlm-429	61	20	results	result	NOUN
ajlm-429	61	21	on	on	ADP
ajlm-429	61	22	the	the	DET
ajlm-429	61	23	same	same	ADJ
ajlm-429	61	24	individuals	individual	NOUN
ajlm-429	61	25	.	.	PUNCT
ajlm-429	62	1	while	while	SCONJ
ajlm-429	62	2	dbs	dbs	PROPN
ajlm-429	62	3	would	would	AUX
ajlm-429	62	4	be	be	AUX
ajlm-429	62	5	an	an	DET
ajlm-429	62	6	appealing	appealing	ADJ
ajlm-429	62	7	and	and	CCONJ
ajlm-429	62	8	relatively	relatively	ADV
ajlm-429	62	9	simple	simple	ADJ
ajlm-429	62	10	means	mean	NOUN
ajlm-429	62	11	for	for	ADP
ajlm-429	62	12	biomarker	biomarker	NOUN
ajlm-429	62	13	-	-	PUNCT
ajlm-429	62	14	based	base	VERB
ajlm-429	62	15	studies	study	NOUN
ajlm-429	62	16	,	,	PUNCT
ajlm-429	62	17	particularly	particularly	ADV
ajlm-429	62	18	in	in	ADP
ajlm-429	62	19	resource	resource	NOUN
ajlm-429	62	20	-	-	PUNCT
ajlm-429	62	21	constrained	constrain	VERB
ajlm-429	62	22	settings	setting	NOUN
ajlm-429	62	23	,	,	PUNCT
ajlm-429	62	24	the	the	DET
ajlm-429	62	25	accuracy	accuracy	NOUN
ajlm-429	62	26	of	of	ADP
ajlm-429	62	27	this	this	DET
ajlm-429	62	28	testing	testing	NOUN
ajlm-429	62	29	format	format	NOUN
ajlm-429	62	30	would	would	AUX
ajlm-429	62	31	need	need	VERB
ajlm-429	62	32	to	to	PART
ajlm-429	62	33	be	be	AUX
ajlm-429	62	34	substantially	substantially	ADV
ajlm-429	62	35	improved	improve	VERB
ajlm-429	62	36	before	before	SCONJ
ajlm-429	62	37	its	its	PRON
ajlm-429	62	38	use	use	NOUN
ajlm-429	62	39	could	could	AUX
ajlm-429	62	40	be	be	AUX
ajlm-429	62	41	recommended	recommend	VERB
ajlm-429	62	42	for	for	ADP
ajlm-429	62	43	epidemiological	epidemiological	ADJ
ajlm-429	62	44	studies	study	NOUN
ajlm-429	62	45	.	.	PUNCT
ajlm-429	63	1	acknowledgements	acknowledgement	NOUN
ajlm-429	63	2	the	the	DET
ajlm-429	63	3	authors	author	NOUN
ajlm-429	63	4	would	would	AUX
ajlm-429	63	5	like	like	VERB
ajlm-429	63	6	to	to	PART
ajlm-429	63	7	thank	thank	VERB
ajlm-429	63	8	angele	angele	PROPN
ajlm-429	63	9	marandet	marandet	PROPN
ajlm-429	63	10	and	and	CCONJ
ajlm-429	63	11	wolfgang	wolfgang	PROPN
ajlm-429	63	12	hladik	hladik	PROPN
ajlm-429	63	13	at	at	ADP
ajlm-429	63	14	the	the	DET
ajlm-429	63	15	united	united	PROPN
ajlm-429	63	16	states	states	PROPN
ajlm-429	63	17	centers	center	NOUN
ajlm-429	63	18	for	for	ADP
ajlm-429	63	19	disease	disease	NOUN
ajlm-429	63	20	control	control	NOUN
ajlm-429	63	21	for	for	ADP
ajlm-429	63	22	their	their	PRON
ajlm-429	63	23	support	support	NOUN
ajlm-429	63	24	and	and	CCONJ
ajlm-429	63	25	encouragement	encouragement	NOUN
ajlm-429	63	26	in	in	ADP
ajlm-429	63	27	the	the	DET
ajlm-429	63	28	development	development	NOUN
ajlm-429	63	29	of	of	ADP
ajlm-429	63	30	the	the	DET
ajlm-429	63	31	manuscript	manuscript	NOUN
ajlm-429	63	32	.	.	PUNCT
ajlm-429	64	1	we	we	PRON
ajlm-429	64	2	also	also	ADV
ajlm-429	64	3	thank	thank	VERB
ajlm-429	64	4	joshua	joshua	PROPN
ajlm-429	64	5	musinguzi	musinguzi	PROPN
ajlm-429	64	6	of	of	ADP
ajlm-429	64	7	the	the	DET
ajlm-429	64	8	ministry	ministry	PROPN
ajlm-429	64	9	of	of	ADP
ajlm-429	64	10	health	health	PROPN
ajlm-429	64	11	,	,	PUNCT
ajlm-429	64	12	aids	aids	PROPN
ajlm-429	64	13	control	control	NOUN
ajlm-429	64	14	programme	programme	PROPN
ajlm-429	64	15	in	in	ADP
ajlm-429	64	16	uganda	uganda	PROPN
ajlm-429	64	17	for	for	ADP
ajlm-429	64	18	his	his	PRON
ajlm-429	64	19	assistance	assistance	NOUN
ajlm-429	64	20	in	in	ADP
ajlm-429	64	21	design	design	NOUN
ajlm-429	64	22	and	and	CCONJ
ajlm-429	64	23	execution	execution	NOUN
ajlm-429	64	24	of	of	ADP
ajlm-429	64	25	the	the	DET
ajlm-429	64	26	study	study	NOUN
ajlm-429	64	27	.	.	PUNCT
ajlm-429	65	1	competing	compete	VERB
ajlm-429	65	2	interests	interest	NOUN
ajlm-429	65	3	the	the	DET
ajlm-429	65	4	authors	author	NOUN
ajlm-429	65	5	declare	declare	VERB
ajlm-429	65	6	that	that	SCONJ
ajlm-429	65	7	they	they	PRON
ajlm-429	65	8	have	have	VERB
ajlm-429	65	9	no	no	DET
ajlm-429	65	10	financial	financial	ADJ
ajlm-429	65	11	or	or	CCONJ
ajlm-429	65	12	personal	personal	ADJ
ajlm-429	65	13	relationship(s	relationship(s	NOUN
ajlm-429	65	14	)	)	PUNCT
ajlm-429	65	15	which	which	PRON
ajlm-429	65	16	may	may	AUX
ajlm-429	65	17	have	have	AUX
ajlm-429	65	18	inappropriately	inappropriately	ADV
ajlm-429	65	19	influenced	influence	VERB
ajlm-429	65	20	them	they	PRON
ajlm-429	65	21	in	in	ADP
ajlm-429	65	22	writing	write	VERB
ajlm-429	65	23	this	this	DET
ajlm-429	65	24	article	article	NOUN
ajlm-429	65	25	.	.	PUNCT
ajlm-429	66	1	sources	source	NOUN
ajlm-429	66	2	of	of	ADP
ajlm-429	66	3	support	support	NOUN
ajlm-429	66	4	the	the	DET
ajlm-429	66	5	study	study	NOUN
ajlm-429	66	6	was	be	AUX
ajlm-429	66	7	funded	fund	VERB
ajlm-429	66	8	by	by	ADP
ajlm-429	66	9	the	the	DET
ajlm-429	66	10	national	national	PROPN
ajlm-429	66	11	institutes	institutes	PROPN
ajlm-429	66	12	of	of	ADP
ajlm-429	66	13	health	health	PROPN
ajlm-429	66	14	grant	grant	PROPN
ajlm-429	66	15	number	number	PROPN
ajlm-429	66	16	r01	r01	PROPN
ajlm-429	66	17	hd	hd	PROPN
ajlm-429	66	18	047764	047764	NUM
ajlm-429	66	19	s1	s1	PROPN
ajlm-429	66	20	,	,	PUNCT
ajlm-429	66	21	barbara	barbara	PROPN
ajlm-429	66	22	s.	s.	PROPN
ajlm-429	66	23	mensch	mensch	PROPN
ajlm-429	66	24	principal	principal	PROPN
ajlm-429	66	25	investigator	investigator	NOUN
ajlm-429	66	26	,	,	PUNCT
ajlm-429	66	27	paul	paul	PROPN
ajlm-429	66	28	c.	c.	PROPN
ajlm-429	66	29	hewett	hewett	PROPN
ajlm-429	66	30	,	,	PUNCT
ajlm-429	66	31	co	co	ADJ
ajlm-429	66	32	-	-	ADJ
ajlm-429	66	33	principal	principal	ADJ
ajlm-429	66	34	investigator	investigator	NOUN
ajlm-429	66	35	.	.	PUNCT
ajlm-429	67	1	author	author	NOUN
ajlm-429	67	2	contributions	contribution	NOUN
ajlm-429	67	3	s.l.n	s.l.n	VERB
ajlm-429	67	4	.	.	PUNCT
ajlm-429	68	1	drafted	draft	VERB
ajlm-429	68	2	the	the	DET
ajlm-429	68	3	manuscript	manuscript	NOUN
ajlm-429	68	4	,	,	PUNCT
ajlm-429	68	5	which	which	PRON
ajlm-429	68	6	was	be	AUX
ajlm-429	68	7	reviewed	review	VERB
ajlm-429	68	8	and	and	CCONJ
ajlm-429	68	9	contributed	contribute	VERB
ajlm-429	68	10	to	to	ADP
ajlm-429	68	11	by	by	ADP
ajlm-429	68	12	p.c.h	p.c.h	NOUN
ajlm-429	68	13	.	.	PUNCT
ajlm-429	68	14	,	,	PUNCT
ajlm-429	68	15	s.k	s.k	PROPN
ajlm-429	68	16	.	.	PROPN
ajlm-429	68	17	and	and	CCONJ
ajlm-429	68	18	b.s.m	b.s.m	PROPN
ajlm-429	68	19	.	.	PUNCT
ajlm-429	69	1	s.l.n	s.l.n	PROPN
ajlm-429	69	2	.	.	PUNCT
ajlm-429	70	1	oversaw	oversee	VERB
ajlm-429	70	2	the	the	DET
ajlm-429	70	3	testing	testing	NOUN
ajlm-429	70	4	of	of	ADP
ajlm-429	70	5	specimens	specimen	NOUN
ajlm-429	70	6	in	in	ADP
ajlm-429	70	7	the	the	DET
ajlm-429	70	8	laboratory	laboratory	NOUN
ajlm-429	70	9	and	and	CCONJ
ajlm-429	70	10	the	the	DET
ajlm-429	70	11	reporting	reporting	NOUN
ajlm-429	70	12	of	of	ADP
ajlm-429	70	13	the	the	DET
ajlm-429	70	14	test	test	NOUN
ajlm-429	70	15	results	result	NOUN
ajlm-429	70	16	.	.	PUNCT
ajlm-429	71	1	s.l.n	s.l.n	NOUN
ajlm-429	71	2	.	.	PUNCT
ajlm-429	72	1	and	and	CCONJ
ajlm-429	72	2	p.c.h	p.c.h	VERB
ajlm-429	72	3	.	.	PUNCT
ajlm-429	73	1	contributed	contribute	VERB
ajlm-429	73	2	to	to	ADP
ajlm-429	73	3	the	the	DET
ajlm-429	73	4	analysis	analysis	NOUN
ajlm-429	73	5	of	of	ADP
ajlm-429	73	6	the	the	DET
ajlm-429	73	7	results	result	NOUN
ajlm-429	73	8	.	.	PUNCT
ajlm-429	74	1	b.s.m	b.s.m	PROPN
ajlm-429	74	2	.	.	PUNCT
ajlm-429	75	1	and	and	CCONJ
ajlm-429	75	2	p.c.h	p.c.h	VERB
ajlm-429	75	3	.	.	PUNCT
ajlm-429	76	1	conceived	conceive	VERB
ajlm-429	76	2	of	of	ADP
ajlm-429	76	3	the	the	DET
ajlm-429	76	4	original	original	ADJ
ajlm-429	76	5	study	study	NOUN
ajlm-429	76	6	,	,	PUNCT
ajlm-429	76	7	with	with	ADP
ajlm-429	76	8	s.l.n	s.l.n	NOUN
ajlm-429	76	9	.	.	PUNCT
ajlm-429	77	1	and	and	CCONJ
ajlm-429	77	2	s.k	s.k	PROPN
ajlm-429	77	3	.	.	AUX
ajlm-429	77	4	assisting	assist	VERB
ajlm-429	77	5	with	with	ADP
ajlm-429	77	6	its	its	PRON
ajlm-429	77	7	design	design	NOUN
ajlm-429	77	8	and	and	CCONJ
ajlm-429	77	9	execution	execution	NOUN
ajlm-429	77	10	.	.	PUNCT
ajlm-429	78	1	references	reference	NOUN
ajlm-429	78	2	laeyendecker	laeyendecker	PROPN
ajlm-429	78	3	o	o	PROPN
ajlm-429	78	4	,	,	PUNCT
ajlm-429	78	5	henson	henson	PROPN
ajlm-429	78	6	c	c	PROPN
ajlm-429	78	7	,	,	PUNCT
ajlm-429	78	8	gray	gray	PROPN
ajlm-429	78	9	rh	rh	PROPN
ajlm-429	78	10	,	,	PUNCT
ajlm-429	78	11	et	et	PROPN
ajlm-429	78	12	al	al	PROPN
ajlm-429	78	13	.	.	PUNCT
ajlm-429	78	14	performance	performance	NOUN
ajlm-429	78	15	of	of	ADP
ajlm-429	78	16	a	a	DET
ajlm-429	78	17	commercial	commercial	ADJ
ajlm-429	78	18	,	,	PUNCT
ajlm-429	78	19	type	type	NOUN
ajlm-429	78	20	-	-	PUNCT
ajlm-429	78	21	specific	specific	ADJ
ajlm-429	78	22	enzyme	enzyme	NOUN
ajlm-429	78	23	-	-	PUNCT
ajlm-429	78	24	linked	link	VERB
ajlm-429	78	25	immunosorbent	immunosorbent	NOUN
ajlm-429	78	26	assay	assay	NOUN
ajlm-429	78	27	for	for	ADP
ajlm-429	78	28	detection	detection	NOUN
ajlm-429	78	29	of	of	ADP
ajlm-429	78	30	herpes	herpe	NOUN
ajlm-429	78	31	simplex	simplex	NOUN
ajlm-429	78	32	virus	virus	NOUN
ajlm-429	78	33	type	type	NOUN
ajlm-429	78	34	2	2	NUM
ajlm-429	78	35	-	-	PUNCT
ajlm-429	78	36	specific	specific	ADJ
ajlm-429	78	37	antibodies	antibody	NOUN
ajlm-429	78	38	in	in	ADP
ajlm-429	78	39	ugandans	ugandans	PROPN
ajlm-429	78	40	.	.	PUNCT
ajlm-429	79	1	j	j	PROPN
ajlm-429	79	2	clin	clin	PROPN
ajlm-429	79	3	microbiol	microbiol	PROPN
ajlm-429	79	4	.	.	PUNCT
ajlm-429	80	1	2004;42(4	2004;42(4	NUM
ajlm-429	80	2	):	):	PUNCT
ajlm-429	80	3	1794–1796	1794–1796	NUM
ajlm-429	80	4	.	.	PUNCT
ajlm-429	81	1	http://dx.doi.org/10.1128/jcm.42.4.1794-1796.2004	http://dx.doi.org/10.1128/jcm.42.4.1794-1796.2004	NOUN
ajlm-429	82	1	macro	macro	NOUN
ajlm-429	82	2	o.	o.	PROPN
ajlm-429	83	1	uganda	uganda	PROPN
ajlm-429	83	2	hiv	hiv	PROPN
ajlm-429	83	3	/	/	SYM
ajlm-429	83	4	aids	aids	PROPN
ajlm-429	83	5	sero	sero	ADJ
ajlm-429	83	6	-	-	PUNCT
ajlm-429	83	7	behavioural	behavioural	ADJ
ajlm-429	83	8	survey	survey	NOUN
ajlm-429	83	9	:	:	PUNCT
ajlm-429	83	10	2004–2005	2004–2005	NUM
ajlm-429	83	11	.	.	PUNCT
ajlm-429	84	1	ministry	ministry	PROPN
ajlm-429	84	2	of	of	ADP
ajlm-429	84	3	health	health	PROPN
ajlm-429	84	4	;	;	PUNCT
ajlm-429	84	5	2006	2006	NUM
ajlm-429	84	6	.	.	PUNCT
ajlm-429	85	1	bailey	bailey	PROPN
ajlm-429	85	2	nm	nm	PROPN
ajlm-429	85	3	,	,	PUNCT
ajlm-429	85	4	cunningham	cunningham	PROPN
ajlm-429	85	5	mp	mp	PROPN
ajlm-429	85	6	,	,	PUNCT
ajlm-429	85	7	kimber	kimber	PROPN
ajlm-429	85	8	cd	cd	PROPN
ajlm-429	85	9	.	.	PUNCT
ajlm-429	86	1	the	the	DET
ajlm-429	86	2	indirect	indirect	ADJ
ajlm-429	86	3	fluorescent	fluorescent	ADJ
ajlm-429	86	4	antibody	antibody	NOUN
ajlm-429	86	5	technique	technique	NOUN
ajlm-429	86	6	applied	apply	VERB
ajlm-429	86	7	to	to	ADP
ajlm-429	86	8	dried	dry	VERB
ajlm-429	86	9	blood	blood	NOUN
ajlm-429	86	10	,	,	PUNCT
ajlm-429	86	11	for	for	ADP
ajlm-429	86	12	use	use	NOUN
ajlm-429	86	13	as	as	ADP
ajlm-429	86	14	a	a	DET
ajlm-429	86	15	screening	screening	NOUN
ajlm-429	86	16	test	test	NOUN
ajlm-429	86	17	in	in	ADP
ajlm-429	86	18	the	the	DET
ajlm-429	86	19	diagnosis	diagnosis	NOUN
ajlm-429	86	20	of	of	ADP
ajlm-429	86	21	human	human	ADJ
ajlm-429	86	22	trypanosomiasis	trypanosomiasis	NOUN
ajlm-429	86	23	in	in	ADP
ajlm-429	86	24	africa	africa	PROPN
ajlm-429	86	25	.	.	PUNCT
ajlm-429	87	1	trans	trans	PROPN
ajlm-429	87	2	r	r	PROPN
ajlm-429	87	3	soc	soc	PROPN
ajlm-429	87	4	trop	trop	X
ajlm-429	87	5	med	med	PROPN
ajlm-429	87	6	hyg	hyg	PROPN
ajlm-429	87	7	.	.	PROPN
ajlm-429	87	8	1967;61(5):696–700	1967;61(5):696–700	NUM
ajlm-429	87	9	.	.	PUNCT
ajlm-429	87	10	http://dx.doi.org/10.1016/0035-9203(67)90135-6	http://dx.doi.org/10.1016/0035-9203(67)90135-6	PROPN
ajlm-429	87	11	beebe	beebe	PROPN
ajlm-429	87	12	jl	jl	PROPN
ajlm-429	87	13	,	,	PUNCT
ajlm-429	87	14	briggs	briggs	PROPN
ajlm-429	87	15	lc	lc	PROPN
ajlm-429	87	16	.	.	PUNCT
ajlm-429	87	17	evaluation	evaluation	NOUN
ajlm-429	87	18	of	of	ADP
ajlm-429	87	19	enzyme	enzyme	NOUN
ajlm-429	87	20	-	-	PUNCT
ajlm-429	87	21	linked	link	VERB
ajlm-429	87	22	immunoassay	immunoassay	ADJ
ajlm-429	87	23	systems	system	NOUN
ajlm-429	87	24	for	for	ADP
ajlm-429	87	25	detection	detection	NOUN
ajlm-429	87	26	of	of	ADP
ajlm-429	87	27	human	human	ADJ
ajlm-429	87	28	immunodeficiency	immunodeficiency	NOUN
ajlm-429	87	29	virus	virus	NOUN
ajlm-429	87	30	type	type	NOUN
ajlm-429	87	31	1	1	NUM
ajlm-429	87	32	antibody	antibody	NOUN
ajlm-429	87	33	from	from	ADP
ajlm-429	87	34	filter	filter	NOUN
ajlm-429	87	35	paper	paper	NOUN
ajlm-429	87	36	disks	disk	NOUN
ajlm-429	87	37	impregnated	impregnate	VERB
ajlm-429	87	38	with	with	ADP
ajlm-429	87	39	whole	whole	ADJ
ajlm-429	87	40	blood	blood	NOUN
ajlm-429	87	41	.	.	PUNCT
ajlm-429	88	1	j	j	PROPN
ajlm-429	88	2	clin	clin	PROPN
ajlm-429	88	3	microbiol	microbiol	PROPN
ajlm-429	88	4	.	.	PUNCT
ajlm-429	89	1	1990;28(4):808–810	1990;28(4):808–810	X
ajlm-429	89	2	.	.	PUNCT
ajlm-429	89	3	brody	brody	PROPN
ajlm-429	89	4	ja	ja	PROPN
ajlm-429	89	5	,	,	PUNCT
ajlm-429	89	6	mcalister	mcalister	PROPN
ajlm-429	89	7	r	r	PROPN
ajlm-429	89	8	,	,	PUNCT
ajlm-429	89	9	haseley	haseley	NOUN
ajlm-429	89	10	r	r	PROPN
ajlm-429	89	11	,	,	PUNCT
ajlm-429	89	12	lee	lee	PROPN
ajlm-429	89	13	p.	p.	NOUN
ajlm-429	89	14	use	use	NOUN
ajlm-429	89	15	of	of	ADP
ajlm-429	89	16	dried	dry	VERB
ajlm-429	89	17	whole	whole	ADJ
ajlm-429	89	18	blood	blood	NOUN
ajlm-429	89	19	collected	collect	VERB
ajlm-429	89	20	on	on	ADP
ajlm-429	89	21	filter	filter	NOUN
ajlm-429	89	22	paper	paper	NOUN
ajlm-429	89	23	disks	disk	NOUN
ajlm-429	89	24	in	in	ADP
ajlm-429	89	25	adenovirus	adenovirus	NOUN
ajlm-429	89	26	complement	complement	NOUN
ajlm-429	89	27	fixation	fixation	NOUN
ajlm-429	89	28	and	and	CCONJ
ajlm-429	89	29	measles	measle	NOUN
ajlm-429	89	30	hemagglutination	hemagglutination	NOUN
ajlm-429	89	31	inhibition	inhibition	NOUN
ajlm-429	89	32	tests	test	NOUN
ajlm-429	89	33	.	.	PUNCT
ajlm-429	90	1	j	j	PROPN
ajlm-429	90	2	immunol	immunol	NOUN
ajlm-429	90	3	.	.	PUNCT
ajlm-429	91	1	1964;92(6):854–857	1964;92(6):854–857	NUM
ajlm-429	91	2	.	.	X
ajlm-429	91	3	jafri	jafri	PROPN
ajlm-429	91	4	hs	hs	PROPN
ajlm-429	91	5	,	,	PUNCT
ajlm-429	91	6	torrico	torrico	NOUN
ajlm-429	91	7	f	f	PROPN
ajlm-429	91	8	,	,	PUNCT
ajlm-429	91	9	noh	noh	PROPN
ajlm-429	91	10	jc	jc	PROPN
ajlm-429	91	11	,	,	PUNCT
ajlm-429	91	12	et	et	PROPN
ajlm-429	91	13	al	al	PROPN
ajlm-429	91	14	.	.	PUNCT
ajlm-429	91	15	application	application	NOUN
ajlm-429	91	16	of	of	ADP
ajlm-429	91	17	the	the	DET
ajlm-429	91	18	enzyme	enzyme	NOUN
ajlm-429	91	19	-	-	PUNCT
ajlm-429	91	20	linked	link	VERB
ajlm-429	91	21	immunoelectrotransfer	immunoelectrotransfer	ADJ
ajlm-429	91	22	blot	blot	NOUN
ajlm-429	91	23	to	to	ADP
ajlm-429	91	24	filter	filter	NOUN
ajlm-429	91	25	paper	paper	NOUN
ajlm-429	91	26	blood	blood	NOUN
ajlm-429	91	27	spots	spot	NOUN
ajlm-429	91	28	to	to	PART
ajlm-429	91	29	estimate	estimate	VERB
ajlm-429	91	30	seroprevalence	seroprevalence	NOUN
ajlm-429	91	31	of	of	ADP
ajlm-429	91	32	cysticercosis	cysticercosis	NOUN
ajlm-429	91	33	in	in	ADP
ajlm-429	91	34	bolivia	bolivia	PROPN
ajlm-429	91	35	.	.	PUNCT
ajlm-429	92	1	am	be	AUX
ajlm-429	92	2	j	j	PROPN
ajlm-429	92	3	trop	trop	X
ajlm-429	92	4	med	med	PROPN
ajlm-429	92	5	hyg	hyg	PROPN
ajlm-429	92	6	.	.	PUNCT
ajlm-429	93	1	1998;58(3):313–315	1998;58(3):313–315	NUM
ajlm-429	93	2	.	.	PUNCT
ajlm-429	93	3	takkouche	takkouche	PROPN
ajlm-429	93	4	b	b	PROPN
ajlm-429	93	5	,	,	PUNCT
ajlm-429	93	6	iglesias	iglesias	PROPN
ajlm-429	93	7	j	j	PROPN
ajlm-429	93	8	,	,	PUNCT
ajlm-429	93	9	alonso	alonso	PROPN
ajlm-429	93	10	-	-	PUNCT
ajlm-429	93	11	fernandez	fernandez	PROPN
ajlm-429	93	12	jr	jr	PROPN
ajlm-429	93	13	,	,	PUNCT
ajlm-429	93	14	fernandez	fernandez	PROPN
ajlm-429	93	15	-	-	PUNCT
ajlm-429	93	16	gonzalez	gonzalez	PROPN
ajlm-429	93	17	c	c	PROPN
ajlm-429	93	18	,	,	PUNCT
ajlm-429	93	19	gestal	gestal	PROPN
ajlm-429	93	20	-	-	PUNCT
ajlm-429	93	21	otero	otero	PROPN
ajlm-429	93	22	jj	jj	PROPN
ajlm-429	93	23	.	.	PROPN
ajlm-429	93	24	detection	detection	NOUN
ajlm-429	93	25	of	of	ADP
ajlm-429	93	26	brucella	brucella	PROPN
ajlm-429	93	27	antibodies	antibodie	VERB
ajlm-429	93	28	in	in	ADP
ajlm-429	93	29	eluted	eluted	ADJ
ajlm-429	93	30	dried	dried	ADJ
ajlm-429	93	31	blood	blood	NOUN
ajlm-429	93	32	:	:	PUNCT
ajlm-429	93	33	a	a	DET
ajlm-429	93	34	validation	validation	NOUN
ajlm-429	93	35	study	study	NOUN
ajlm-429	93	36	.	.	PUNCT
ajlm-429	94	1	immunol	immunol	PROPN
ajlm-429	94	2	lett	lett	PROPN
ajlm-429	94	3	.	.	PUNCT
ajlm-429	95	1	1995;45(1–2):107–108	1995;45(1–2):107–108	NUM
ajlm-429	95	2	.	.	PUNCT
ajlm-429	96	1	http://dx.doi.org/10.1016/0165-2478(94)00247-o	http://dx.doi.org/10.1016/0165-2478(94)00247-o	PROPN
ajlm-429	96	2	ashley	ashley	PROPN
ajlm-429	96	3	rl	rl	PROPN
ajlm-429	96	4	,	,	PUNCT
ajlm-429	96	5	wald	wald	PROPN
ajlm-429	96	6	a.	a.	NOUN
ajlm-429	96	7	genital	genital	ADJ
ajlm-429	96	8	herpes	herpe	NOUN
ajlm-429	96	9	:	:	PUNCT
ajlm-429	96	10	review	review	NOUN
ajlm-429	96	11	of	of	ADP
ajlm-429	96	12	the	the	DET
ajlm-429	96	13	epidemic	epidemic	NOUN
ajlm-429	96	14	and	and	CCONJ
ajlm-429	96	15	potential	potential	ADJ
ajlm-429	96	16	use	use	NOUN
ajlm-429	96	17	of	of	ADP
ajlm-429	96	18	type	type	NOUN
ajlm-429	96	19	-	-	PUNCT
ajlm-429	96	20	specific	specific	ADJ
ajlm-429	96	21	serology	serology	NOUN
ajlm-429	96	22	.	.	PUNCT
ajlm-429	97	1	clin	clin	PROPN
ajlm-429	97	2	microbiol	microbiol	PROPN
ajlm-429	97	3	rev	rev	PROPN
ajlm-429	97	4	.	.	PROPN
ajlm-429	97	5	1999;12(1):1–8	1999;12(1):1–8	PROPN
ajlm-429	97	6	.	.	PUNCT
ajlm-429	98	1	ashley	ashley	PROPN
ajlm-429	98	2	r.	r.	PROPN
ajlm-429	98	3	type	type	PROPN
ajlm-429	98	4	-	-	PUNCT
ajlm-429	98	5	specific	specific	ADJ
ajlm-429	98	6	antibodies	antibody	NOUN
ajlm-429	98	7	to	to	ADP
ajlm-429	98	8	hsv-1	hsv-1	PUNCT
ajlm-429	98	9	and	and	CCONJ
ajlm-429	98	10	-2	-2	NUM
ajlm-429	98	11	:	:	PUNCT
ajlm-429	98	12	review	review	NOUN
ajlm-429	98	13	of	of	ADP
ajlm-429	98	14	methodology	methodology	NOUN
ajlm-429	98	15	.	.	PUNCT
ajlm-429	99	1	herpes	herpe	NOUN
ajlm-429	99	2	.	.	PUNCT
ajlm-429	100	1	1998;5:33–38	1998;5:33–38	NUM
ajlm-429	100	2	.	.	PUNCT
ajlm-429	100	3	hogrefe	hogrefe	PROPN
ajlm-429	100	4	wr	wr	PROPN
ajlm-429	100	5	,	,	PUNCT
ajlm-429	100	6	ernst	ernst	PROPN
ajlm-429	100	7	c	c	PROPN
ajlm-429	100	8	,	,	PUNCT
ajlm-429	100	9	su	su	PROPN
ajlm-429	100	10	x.	x.	NOUN
ajlm-429	100	11	efficiency	efficiency	NOUN
ajlm-429	100	12	of	of	ADP
ajlm-429	100	13	reconstitution	reconstitution	NOUN
ajlm-429	100	14	of	of	ADP
ajlm-429	100	15	immunoglobulin	immunoglobulin	NOUN
ajlm-429	100	16	g	g	NOUN
ajlm-429	100	17	from	from	ADP
ajlm-429	100	18	blood	blood	NOUN
ajlm-429	100	19	specimens	specimen	NOUN
ajlm-429	100	20	dried	dry	VERB
ajlm-429	100	21	on	on	ADP
ajlm-429	100	22	filter	filter	NOUN
ajlm-429	100	23	paper	paper	NOUN
ajlm-429	100	24	and	and	CCONJ
ajlm-429	100	25	utility	utility	NOUN
ajlm-429	100	26	in	in	ADP
ajlm-429	100	27	herpes	herpe	NOUN
ajlm-429	100	28	simplex	simplex	NOUN
ajlm-429	100	29	virus	virus	NOUN
ajlm-429	100	30	type	type	NOUN
ajlm-429	100	31	-	-	PUNCT
ajlm-429	100	32	specific	specific	ADJ
ajlm-429	100	33	serology	serology	NOUN
ajlm-429	100	34	screening	screening	NOUN
ajlm-429	100	35	.	.	PUNCT
ajlm-429	101	1	clin	clin	PROPN
ajlm-429	101	2	diagn	diagn	PROPN
ajlm-429	101	3	lab	lab	NOUN
ajlm-429	101	4	immunol	immunol	NOUN
ajlm-429	101	5	.	.	PUNCT
ajlm-429	102	1	2002;9(6):1338–1342	2002;9(6):1338–1342	NUM
ajlm-429	102	2	.	.	PUNCT
ajlm-429	103	1	http://dx.doi.org/10.1128/cdli.9.6.1338-1342.2002	http://dx.doi.org/10.1128/cdli.9.6.1338-1342.2002	NOUN
ajlm-429	103	2	kelly	kelly	PROPN
ajlm-429	103	3	ca	ca	PROPN
ajlm-429	103	4	,	,	PUNCT
ajlm-429	103	5	hewett	hewett	PROPN
ajlm-429	103	6	pc	pc	PROPN
ajlm-429	103	7	,	,	PUNCT
ajlm-429	103	8	mensch	mensch	PROPN
ajlm-429	103	9	bs	bs	PROPN
ajlm-429	103	10	,	,	PUNCT
ajlm-429	103	11	et	et	PROPN
ajlm-429	103	12	al	al	PROPN
ajlm-429	103	13	.	.	PUNCT
ajlm-429	104	1	using	use	VERB
ajlm-429	104	2	biomarkers	biomarker	NOUN
ajlm-429	104	3	to	to	PART
ajlm-429	104	4	assess	assess	VERB
ajlm-429	104	5	the	the	DET
ajlm-429	104	6	validity	validity	NOUN
ajlm-429	104	7	of	of	ADP
ajlm-429	104	8	sexual	sexual	ADJ
ajlm-429	104	9	behavior	behavior	NOUN
ajlm-429	104	10	reporting	report	VERB
ajlm-429	104	11	across	across	ADP
ajlm-429	104	12	interview	interview	NOUN
ajlm-429	104	13	modes	mode	NOUN
ajlm-429	104	14	among	among	ADP
ajlm-429	104	15	young	young	ADJ
ajlm-429	104	16	women	woman	NOUN
ajlm-429	104	17	in	in	ADP
ajlm-429	104	18	kampala	kampala	PROPN
ajlm-429	104	19	,	,	PUNCT
ajlm-429	104	20	uganda	uganda	PROPN
ajlm-429	104	21	.	.	PUNCT
ajlm-429	105	1	stud	stud	PROPN
ajlm-429	105	2	fam	fam	PROPN
ajlm-429	105	3	plann	plann	PROPN
ajlm-429	105	4	.	.	PUNCT
ajlm-429	106	1	2014;45(1):43–58	2014;45(1):43–58	X
ajlm-429	106	2	.	.	PUNCT
ajlm-429	107	1	http://dx.doi.org/10.1111/j.1728-4465.2014.00375.x	http://dx.doi.org/10.1111/j.1728-4465.2014.00375.x	PROPN
ajlm-429	107	2	lingappa	lingappa	PROPN
ajlm-429	107	3	j	j	PROPN
ajlm-429	107	4	,	,	PUNCT
ajlm-429	107	5	nakku	nakku	NOUN
ajlm-429	107	6	-	-	PUNCT
ajlm-429	107	7	joloba	joloba	PROPN
ajlm-429	107	8	e	e	NOUN
ajlm-429	107	9	,	,	PUNCT
ajlm-429	107	10	magaret	magaret	VERB
ajlm-429	107	11	a	a	PROPN
ajlm-429	107	12	,	,	PUNCT
ajlm-429	107	13	et	et	PROPN
ajlm-429	107	14	al	al	PROPN
ajlm-429	107	15	.	.	PROPN
ajlm-429	107	16	sensitivity	sensitivity	NOUN
ajlm-429	107	17	and	and	CCONJ
ajlm-429	107	18	specificity	specificity	NOUN
ajlm-429	107	19	of	of	ADP
ajlm-429	107	20	herpes	herpe	NOUN
ajlm-429	107	21	simplex	simplex	NOUN
ajlm-429	107	22	virus-2	virus-2	NUM
ajlm-429	107	23	serological	serological	ADJ
ajlm-429	107	24	assays	assay	NOUN
ajlm-429	107	25	among	among	ADP
ajlm-429	107	26	hiv	hiv	PROPN
ajlm-429	107	27	-	-	PUNCT
ajlm-429	107	28	infected	infect	VERB
ajlm-429	107	29	and	and	CCONJ
ajlm-429	107	30	uninfected	uninfected	ADJ
ajlm-429	107	31	urban	urban	ADJ
ajlm-429	107	32	ugandans	ugandans	PROPN
ajlm-429	107	33	.	.	PUNCT
ajlm-429	108	1	int	int	NOUN
ajlm-429	108	2	j	j	PROPN
ajlm-429	108	3	std	std	X
ajlm-429	108	4	aids	aids	PROPN
ajlm-429	108	5	.	.	PUNCT
ajlm-429	109	1	2010;21(9):611–616	2010;21(9):611–616	NUM
ajlm-429	109	2	.	.	PROPN
ajlm-429	109	3	http://dx.doi.org/10.1258/ijsa.2009.008477	http://dx.doi.org/10.1258/ijsa.2009.008477	PROPN
ajlm-429	109	4	delany	delany	PROPN
ajlm-429	109	5	-	-	PUNCT
ajlm-429	109	6	moretlwe	moretlwe	PROPN
ajlm-429	109	7	s	s	PROPN
ajlm-429	109	8	,	,	PUNCT
ajlm-429	109	9	jentsch	jentsch	PROPN
ajlm-429	109	10	u	u	NOUN
ajlm-429	109	11	,	,	PUNCT
ajlm-429	109	12	weiss	weiss	PROPN
ajlm-429	109	13	h	h	NOUN
ajlm-429	109	14	,	,	PUNCT
ajlm-429	109	15	et	et	PROPN
ajlm-429	109	16	al	al	PROPN
ajlm-429	109	17	.	.	PROPN
ajlm-429	109	18	comparison	comparison	NOUN
ajlm-429	109	19	of	of	ADP
ajlm-429	109	20	focus	focus	NOUN
ajlm-429	109	21	herpesselect	herpesselect	NOUN
ajlm-429	109	22	and	and	CCONJ
ajlm-429	109	23	kalon	kalon	PROPN
ajlm-429	109	24	hsv-2	hsv-2	PART
ajlm-429	109	25	gg2	gg2	PROPN
ajlm-429	109	26	elisa	elisa	X
ajlm-429	109	27	serological	serological	ADJ
ajlm-429	109	28	assays	assay	NOUN
ajlm-429	109	29	to	to	PART
ajlm-429	109	30	detect	detect	VERB
ajlm-429	109	31	herpes	herpe	NOUN
ajlm-429	109	32	simplex	simplex	NOUN
ajlm-429	109	33	virus	virus	NOUN
ajlm-429	109	34	type	type	NOUN
ajlm-429	109	35	2	2	NUM
ajlm-429	109	36	antibodies	antibody	NOUN
ajlm-429	109	37	in	in	ADP
ajlm-429	109	38	a	a	DET
ajlm-429	109	39	south	south	ADJ
ajlm-429	109	40	african	african	ADJ
ajlm-429	109	41	population	population	NOUN
ajlm-429	109	42	.	.	PUNCT
ajlm-429	110	1	sex	sex	NOUN
ajlm-429	110	2	transm	transm	PROPN
ajlm-429	110	3	infect	infect	VERB
ajlm-429	110	4	.	.	PUNCT
ajlm-429	111	1	2010;86(1):46–50	2010;86(1):46–50	X
ajlm-429	111	2	.	.	PUNCT
ajlm-429	112	1	http://dx.doi.org/10.1136/sti.2009.036541	http://dx.doi.org/10.1136/sti.2009.036541	PROPN
ajlm-429	113	1	smith	smith	PROPN
ajlm-429	113	2	js	js	PROPN
ajlm-429	113	3	,	,	PUNCT
ajlm-429	113	4	bailey	bailey	PROPN
ajlm-429	113	5	rc	rc	PROPN
ajlm-429	113	6	,	,	PUNCT
ajlm-429	113	7	westreich	westreich	PRON
ajlm-429	113	8	dj	dj	PROPN
ajlm-429	113	9	,	,	PUNCT
ajlm-429	113	10	et	et	PROPN
ajlm-429	113	11	al	al	PROPN
ajlm-429	113	12	.	.	PROPN
ajlm-429	113	13	herpes	herpe	NOUN
ajlm-429	113	14	simplex	simplex	NOUN
ajlm-429	113	15	virus	virus	NOUN
ajlm-429	113	16	type	type	NOUN
ajlm-429	113	17	2	2	NUM
ajlm-429	113	18	antibody	antibody	NOUN
ajlm-429	113	19	detection	detection	NOUN
ajlm-429	113	20	performance	performance	NOUN
ajlm-429	113	21	in	in	ADP
ajlm-429	113	22	kisumu	kisumu	PROPN
ajlm-429	113	23	,	,	PUNCT
ajlm-429	113	24	kenya	kenya	PROPN
ajlm-429	113	25	,	,	PUNCT
ajlm-429	113	26	using	use	VERB
ajlm-429	113	27	the	the	DET
ajlm-429	113	28	herpeselect	herpeselect	NOUN
ajlm-429	113	29	elisa	elisa	NOUN
ajlm-429	113	30	,	,	PUNCT
ajlm-429	113	31	kalon	kalon	PROPN
ajlm-429	113	32	elisa	elisa	PROPN
ajlm-429	113	33	,	,	PUNCT
ajlm-429	113	34	western	western	ADJ
ajlm-429	113	35	blot	blot	NOUN
ajlm-429	113	36	and	and	CCONJ
ajlm-429	113	37	inhibition	inhibition	NOUN
ajlm-429	113	38	testing	testing	NOUN
ajlm-429	113	39	.	.	PUNCT
ajlm-429	114	1	sex	sex	NOUN
ajlm-429	114	2	transm	transm	PROPN
ajlm-429	114	3	infect	infect	VERB
ajlm-429	114	4	.	.	PUNCT
ajlm-429	115	1	2009;85(2):92–96	2009;85(2):92–96	NUM
ajlm-429	115	2	.	.	PUNCT
ajlm-429	115	3	http://dx.doi.org/10.1136/sti.2008.031815	http://dx.doi.org/10.1136/sti.2008.031815	NOUN